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Abstract 
 
Many health care professionals and patients are unclear of the role that dentists 
may play in the management of Obstructive Sleep Apnoea-Hypopnoea Syndrome 
(OSAHS.) The dentists’ role is primarily in the construction of appliances for 
OSAHS but in the United States of America some dentists have practices limited 
to “Sleep dentistry”. However, in the United Kingdom there is limited training 
for dentists in this field. 
This thesis aims to review the relevant literature that pertains to OSAHS and 
dentistry and then, through three studies, to look at the past, present and 
future involvement of dentists in OSAHS. Assessing outcome is clearly important 
and this thesis firstly presents patient-based findings of the long term success of 
mandibular advancement appliances. Secondly, the experience and views of 
dentists and sleep specialists, assessed by questionnaire, is presented. Finally, a 
prospective study of a promising screening tool (the Kushida Index) for the 
diagnosis of sleep apnoea is carried out. 3 
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Definitions and abbreviations 
 
OSAHS – Obstructive Sleep Apnoea-Hypopnoea Syndrome. 
REM – Rapid eye movement (sleep). 
NREM – Non-rapid eye movement (sleep). 
CPAP – Continuous Positive Airway Pressure. 
AHI – Apnoea Hypopnoea Index. 
RDI – Respiratory Disturbance Index. 
BMI – Body Mass Index (weight (kg) / height (m) 
2). 
CT – Computed Tomography. 
MRI – Magnetic Resonance Imaging. 
EMG – Electromyogram. 
ESS – Epworth Sleepiness Scale. 
MSLT – Multiple Sleep Latency Test. 
SIGN – Scottish Intercollegiate Guidelines Network. 
SSS – Stanford Sleepiness Scale. 
UPPP – Uvulopalatopharyngoplasty. 
LAUP – Laser-assisted uvulopalatopharyngoplasty. 
NICE – National Institute for Health and Clinical Excellence. 
UARS – Upper airways resistance syndrome. 
ICSD – International classification of sleep disorders. 
MAA – Mandibular advancement appliances. 
STARD – Standards for reporting of diagnostic accuracy. 
ODI – Oxygen Desaturation Index. 
ROC – Receiver Operator Curve. 
ARTP – Association of Respiratory Technology and Physiology. 
 Chapter 1    11 
Chapter 1- Review of the literature 
1.1  Sleep  
Sleep is something that we are all very familiar with, but a suitably precise 
definition might be “A reversible behavioural state of perpetual disengagement 
from and unresponsiveness to the environment.” (Carskadon, Dement 2005) The 
functions of sleep are uncertain but can be categorized into biochemical, 
physiological, neurological, psychological and social. (Shneerson 2005) 
Physiological studies have shown there are two main types of sleep which are 
distinct from one another: (a) rapid eye movement (REM) sleep and (b) non-rapid 
eye movement (NREM) sleep. In addition to episodic bursts of rapid eye 
movement, REM sleep is characterized by muscle atonia and increased 
electroencephalogram (EEG) activity. The mental activity of REM sleep is 
associated with dreaming in 80% of cases. (Dement, Kleitman 1957) In contrast, 
NREM sleep usually is subdivided into four stages, and is associated with minimal 
mental activity. Sleep usually begins with an NREM stage, and REM sleep does 
not occur until 80 minutes or longer thereafter. NREM and REM sleep then 
alternate through the night with an approximately 90 minute cycle. (Carskadon, 
Dement 2005) A normal adult hypnogram is shown in Figure 1.1.  
 
Figure 1.1 A normal adult hypnogram 
 
NREM sleep can be called orthodox sleep, synchronized sleep or quiet sleep 
(infants). Stages 1 and 2 of NREM sleep are light sleep. Stages 3 and 4 are deep 
sleep, slow-wave sleep and Delta sleep. REM sleep can be called paradoxical 
sleep, desynchronised sleep or active sleep (infants).   Chapter 1        12 
The majority (60%) of the adult population in the UK obtain 7-8 hours sleep a 
night, but some (~8%) sleep less than 5 hours per day and few (2%) sleep more 
than 10 hours per day. (Groeger, Zijlstra et al. 2004) Loss of NREM sleep in 
stages 3 and 4 particularly, probably causes more daytime sleepiness than loss of 
REM sleep. (Shneerson 2005) 
Most studies of the function of sleep are based upon sleep deprivation, which 
show that the long term consequences of inadequate sleep are severely reduced 
performance, bizarre behaviour, and (in animal experiments) eventual death.  
(Shneerson 2005, Rechtschaffen, Bergmann et al. 1989) Research into sleep 
restriction in humans found that sleeping 6 hours or less per night produced 
cognitive performance deficits equivalent to up to 2 nights of total sleep 
deprivation. (Van Dongen, Maislin et al. 2003) 
Sleep may have a function in wound healing as this, and the immune response, 
was impaired in sleep-deprived rats. (Gumustekin, Seven et al. 2004, Zager, 
Andersen et al. 2007) Sleep may also have an effect on anabolic activity and 
memory processing. (Turner, Drummond et al. 2007) There are beliefs that sleep 
has a function in preservation and protection, and that dreaming is an important 
process, but this is based on subjective opinion rather than objective data. 
Despite the lack of outcomes from sleep research into the reasons why we sleep, 
we know that people need to sleep in order to function successfully. (Shneerson 
2005) 
1.2 Snoring 
Sleep apnoea and snoring are often confused; snoring is simply the abnormal 
noise made whilst sleeping, whereas sleep apnoea is a disorder where the 
individual commonly snores, but also has cessation of breathing. 
1.2.1 Snoring overview 
Snoring is defined by the International Classification of Sleep Disorders as “Loud 
upper airway breathing sounds in sleep, without episodes of apnea or 
hypoventilation”. (Thorpy 1990, revised 1997 and 2005, Guilleminault, Stoohs et 
al. 1991a). It is an inspiratory noise caused by the vibration of the soft tissues of 
the pharynx, soft palate, and sometimes the uvula, although it is recognised that Chapter 1        13 
there can be expiratory noises also. It has a distinct sound unlike that of other 
respiratory sounds, such as wheezes and coughs. (Perez-Padilla, Slawinski et al. 
1993) 
The social disturbance caused by the snorer can result in marital disharmony. In 
a Scottish study it was found that 85% of snorers were sleeping in a separate 
room from their partner due to their snoring noise. (Armstrong, Wallace et al. 
1999) According to the Guinness Book of World Records, the loudest recorded 
snore measured 93 decibels in 1993 by Kare Walkert, equivalent to the sound of 
a lawnmower or chain-saw. (Guinness World Records 1994) 
Snoring is more common in males than females, and in overweight people of 
both sexes. Its prevalence rises markedly after the age of 40 yrs, with 63% of 
males and 44 % of females being habitual snorers.(Lugaresi, Cirignotta et al. 
1980) In the UK, a telephone questionnaire study of 4972 people aged between 
15 and 100 years old, found the prevalence of regular snoring to be 40%. 
(Ohayon, Guilleminault et al. 1997) 
1.2.2 Examination of snorers  
Uncomplicated snorers (snorers who do not have sleep apnoea) make up the 
majority of the patients that dentists will see for construction of oral 
appliances. However, as many snorers are unaware of the extent of their snoring 
(Hoffstein, Mateika et al. 1994) it would seem appropriate to ask the patient’s 
bed partner about the problem. This presents a challenge, as many patients will 
attend either without their bed partner or they may live alone. In addition, 
there is variability in snoring intensity and frequency from night to night. 
Comparison between self-reported snoring and objective measurement reveals 
that snorers cannot reliably assess their own snoring level. A study where a sleep 
technician and a snorer both evaluated the snoring noise following a recording of 
the previous night’s polysomnography, revealed a poor correlation.(Hoffstein, 
Mateika et al. 1994)  
In an examination of a chronic snorer, it is good practice to ask the bed partner 
questions on the duration of snoring, loudness, degree of social disruption it has 
caused, if the sleep position has an effect and if there are any signs of cessation 
of breathing whilst sleeping.  The most common risk factors for snoring are Chapter 1        14 
patients who are male, obese, smokers, drink alcohol, and those who take 
tranquilizers or muscle relaxants. (Hoffstein 1996b) If a patient has recent 
awareness of snoring, analysis of the onset of snoring and possible associated 
risk factors is recommended.  
An examination of the nasal passages for signs of obstruction, rhinitis, sinusitis 
or allergies is also considered advisable. (Hoffstein 1996b) Sleep nasendoscopy 
may be carried out to determine the site of vibration, however the results in this 
sedative-induced sleep may not accurately reflect natural sleep. (Agrawal, Stone 
et al. 2002) The use of overnight polysomnography for patients with only snoring 
as a symptom and with no signs of obesity, hypertension, observed apnoeas, or 
daytime dysfunction is not cost effective, as most would have a normal sleep 
study. (Hoffstein 1996b)  
1.2.3 Clinical significance of snoring 
Many studies show an association between sleep apnoea and impaired general 
health (Wright, Johns et al. 1997, Redline, Strohl 1998), but fewer studies have 
compared uncomplicated snoring and health. (Hoffstein 1996a) In addition to the 
obvious social problems with snoring, it has been associated with vascular 
disease, and other conditions such as, daytime dysfunction, asthma and hearing 
loss.  There are contradictory results from the few studies and the current 
thinking is snoring alone has no implications on systemic health. (Guilleminault, 
Stoohs et al. 1991b, Fitzpatrick, Martin et al. 1993, Lu, Peat et al. 2003, Prazic 
1973, Hoffstein, Haight et al. 1999, Sardesai, Tan et al. 2003)The main problems 
with the studies that found an association were the lack of standardised 
assessments of individuals and the presence of confounding factors, mainly 
obesity. 
1.2.4 Treatment of snoring 
If a patient has simple snoring, with no social implications, they may be 
managed by lifestyle advice and made aware of the signs and risk factors for 
sleep apnoea. If the patient has daytime dysfunction due to un-refreshing sleep 
or social issues due to the snoring, the management is similar to that of sleep 
apnoea. The first step is usually lifestyle advice, then possibly nasal medication 
or more commonly oral appliance treatment, followed by continuous positive 
airway pressure (CPAP) and, finally, surgery may be considered. (Hoffstein Chapter 1        15 
1996b, Kushida, Morgenthaler et al. 2006, Hassid, Afrapoli et al. 2002, 
Littlefield, Mair 1999, Nakano, Ikeda et al. 2003) 
All patients, particularly if obese, should be advised to lose weight. (Dixon, 
Schachter et al. 2001) Patients should be advised to limit alcohol intake before 
sleep. (Kara, Zencir et al. 2005) and adopt a lateral sleeping position. A 
retrospective study has shown that lateral sleeping positions decrease snoring in 
patients without sleep apnoea. (Nakano, Ikeda et al. 2003) 
Nasal congestion and increased airway resistance can be related to 
snoring.(Young, Finn et al. 2001) Nasal decongestants, lubricants and nasal 
steroids have been used in patients with nasal symptoms; however there is little 
evidence that these are successful. (Kiely, Nolan et al. 2004) Nasal dilators are 
no better than placebos and controls in randomised clinical trials. (Djupesland, 
Skatvedt et al. 2001)  
CPAP has been shown to stop snoring, with a significant reduction in the mean 
number of snoring episodes per night from 1,015 to 23. (Berry, Block 1984) 
However, compliance with CPAP is the major problem with its use as it is 
estimated that only 50-60% of patients will comply. (Kribbs, Pack et al. 1993, 
McArdle, Devereux et al. 1999, Janson, Noges et al. 2000) Compliance in snorers 
without sleep apnoea, measured by an Apnoea Hypopnoea Index (AHI) <5, was 
poor with only 11 out of 118 patients accepting it. Also, those 11 patients used it 
for only 2.8 +/- 1.5 h per night over six months. (Rauscher, Formanek et al. 
1995) 
Uvulopalatopharyngoplasty was recommended for snoring after it was first used 
to treat sleep apnoea. (Fujita 1984) A tonsillectomy, followed by a partial 
removal of the soft palate, uvula, and pharyngeal arches is carried out under 
general anaesthetic. (Littlefield, Mair 1999) The long term success rates ranged 
from 45% - 53% and patient satisfaction was generally poor. (Hassid, Afrapoli et 
al. 2002, Hicklin, Tostevin et al. 2000)  
For snoring, soft palate implants can be used. This is a procedure, carried out 
under local anaesthetic, in which a hollow introducer needle containing the 
implant is used to pierce the soft palate close to the junction with the hard Chapter 1        16 
palate, into the muscle. The needle is then withdrawn, leaving the implant in 
position. The aim of the procedure is to stiffen the soft palate over subsequent 
weeks as a result of fibrosis. The evidence for these implants is limited to small 
case series and therefore a recent NICE guideline recommended further research 
before widespread clinical use. (National Institute for Health and Clinical 
Excellence (NICE) 2007b)   
The current evidence indicates that oral appliances are suitable for patients 
with snoring, mild-moderate sleep apnoea or where CPAP or surgery has failed. 
(Kushida, Morgenthaler et al. 2006, Scottish Intercollegiate Guidelines Network 
2003) 
1.3 Obstructive sleep apnoea-hypopnoea syndrome 
(OSAHS) 
1.3.1 Overview of OSAHS 
The major health risk associated with snoring is OSAHS and it is important that 
dentists are aware of this syndrome, particularly its pathogenesis and treatment. 
Dentists will treat patients who suffer from OSAHS, and increasingly are asked to 
provide oral appliances for these patients. 
OSAHS is characterised by abnormal breathing during sleep and this causes 
recurrent arousals, sleep fragmentation, and nocturnal hypoxaemia. The 
syndrome includes daytime sleepiness, impaired vigilance and cognitive 
functioning, mood and personality changes, and reduced quality of life. 
(Gastaut, Tassarini et al. 1965, Bassari, Guilleminault 2000) 
OSAHS has also been associated with impaired relationships between spouses and 
partners, decreased alertness and an increased risk of accidents whilst driving. 
(Cartwright, Knight 1987, Horne, Reyner 1995, Maycock 1996, Teran-Santos, 
Jimenez-Gomez et al. 1999, George, Smiley 1999) There is an increased 
incidence of cardiovascular disease proven during a 7 year follow up period in 
previously healthy middle aged men with incompletely treated obstructive sleep 
apnoea. (Peker, Hedner et al. 2002) 
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The sleep deprivation caused by OSAHS has significant effects. If children are 
sleep deprived, they may exhibit hyperactive behaviour and perform worse at 
school. Adults may suffer from decreased academic and occupational 
performance. (Landrigan, Rothschild et al. 2004, Lockley, Cronin et al. 2004) It 
is likely that more than 100,000 motor vehicle accidents annually in the United 
States are caused by driving while drowsy. In the UK, research has shown that 
heavy-goods vehicle drivers are more liable to have accidents if they have signs 
of sleep apnoea. (Maycock 1997) A systematic review of motor vehicle crash risk 
in persons with sleep apnoea demonstrated that people suffering from sleep 
apnoea have a 2-3 times increased risk of a motor vehicle accident. The majority 
of the studies are on men, so the same figure cannot necessarily be applied to 
women. (Ellen, Marshall et al. 2006)A review of major disasters, including the 
“Challenger Disaster”, were officially attributed to sleepiness-related impaired 
judgement in the workplace. (Moss, Sills 1981, United States. Presidential 
Commission on the Space Shuttle Challenger Accident 1986, National Commission 
on Sleep Disorders Research 1992) 
In the late 19th century, there were clinical descriptions of cases of obesity with 
extreme excessive sleepiness. (Peretz 2003) These were similar to the 
description of the fat boy in the Pickwick Papers (Dickens 1835). This led to the 
use of the term "Pickwickian syndrome" to describe the combination of obesity 
and marked excessive sleepiness. However, the meaning of the term Pickwickian 
syndrome became more specific and was restricted to those obese individuals 
who also had hypoventilation during wakefulness. (Burwell, Robin et al. 1956) 
Further studies of individuals with Pickwickian symptoms revealed that they had 
nocturnal cessation of respiration (apnoea). This was found to be due to 
obstruction of the upper airway and thus OSAHS was first recognised. (Gastaut, 
Tassarini et al. 1965)  
Cessation of breathing, or apnoea, is defined as the absence of airflow at the 
nose and mouth for at least 10 seconds, and hypopnoea is a major reduction (> 
50%) in airflow, also for at least 10 seconds. Apnoeas may be “central”, in which 
there is cessation of inspiratory drive, or “obstructive”, in which inspiratory 
efforts continue but are ineffective because of upper airway obstruction. Chapter 1        18 
Apnoeas, hypopnoeas, or increased upper airways resistance all result in a brief 
awakening from sleep caused by the increased respiratory effort, sometimes 
termed “arousals”. (Kimoff, Cheong et al. 1994)  This arousal restores upper 
airway dilating muscle tone and the patient gasps, takes a few deep breaths, 
and falls back to sleep, at which point the upper airway dilating muscles relax 
again and the cycle starts off once more. These episodes of upper airway 
narrowing, terminated by arousal, may recur many hundred times in a night; and 
the recurrent sleep disruption accounts for the daytime symptoms and clinical 
features of the condition. (Douglas, Polo 1994) Essentially the airway narrowing 
leads to increased inspiratory effort, which leads to an arousal (brief 
awakening).  
Of interest was Gould’s work reporting that hypopnoeas can have the same 
consequences as apnoeas. (Gould, Whyte et al. 1988)  
1.3.2 Epidemiology of OSAHS 
The epidemiology of OSAHS has been examined in large cohort studies on 
middle-aged adults in the USA and Australia. (Young, Palta et al. 1993, Bearpark, 
Elliott et al. 1995, Bixler, Vgontzas et al. 1998, Bixler, Vgontzas et al. 2001) The 
studies give similar estimates of the prevalence of the disorder at different 
degrees of severity. For mild OSAHS the prevalence ranges from 17-25.9%, 
moderate OSAHS ranges from 3.1-9.1%, and severe OSAHS ranges from 3.1-4%.  
Prevalence in the middle aged workforce is higher in men (4%) than women (2%), 
but the prevalence in women can increase after menopause. (Young, Palta et al. 
1993)  The peak prevalence is in men between 40-65 years old (4.7%). (Young, 
Palta et al. 1993, Bixler, Vgontzas et al. 1998) OSAHS may increase with age, 
with 62% of people aged 65 and over, having a respiratory disturbance index 
(RDI) of 10 or more. (Ancoli-Israel, Kripke et al. 1991) 
Sleep apnoea is responsible for the majority of referrals to sleep clinics, with 
one study showing that 67.8% of individuals referred to a sleep centre had a 
primary diagnosis of sleep apnoea. (Punjabi, Welch et al. 2000) 
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1.3.3 Risk Factors for OSAHS 
The strongest risk factors for OSAHS are obesity and age greater than 65 years. 
(Bloom, Kaltenborn et al. 1988, Phillips, Cook et al. 1989, Rajala, Partinen et al. 
1991, Levinson, McGarvey et al. 1993, Grunstein, Wilcox et al. 1993, Dealberto, 
Ferber et al. 1994, Strohl, Redline 1996) The body mass index {BMI = (weight in 
kg)/(height in m
2 )}is commonly used to quantify obesity and a BMI of more than 
25kg/m2 has been shown to have a sensitivity of 93% and a specificity of 74% for 
OSAHS. (Grunstein, Wilcox et al. 1993) Men who are obese tend to have fat 
deposits predominantly in the neck and abdomen, in contrast to women, where 
fat deposition is mainly on the hips and legs. The former distribution may be 
related to OSAHS, due to a narrowing of the upper airway, and could explain the 
greater prevalence in males. (Millman, Carlisle et al. 1995, Legato 1997) The 
male to female ratio of patients with OSAHS in community based studies is 2-3:1, 
whereas the ratio for patients attending a clinic is 10-90:1. (Strohl, Redline 
1996)The risk of OSAHS for women increases with obesity and postmenopausal 
status.  
Young et al. reviewed the risk factors for OSAHS and found that in the middle-
aged (30-60 years old) population, obesity was the main factor. (Young, Palta et 
al. 1993, Young, Skatrud et al. 2004) Obesity increases the rate of progression of 
the disease and this is accelerated by further weight gain. (Peppard, Young et 
al. 2000) In the elderly, this may not be as closely associated as screening for 
obesity does not identify sleep apnoea in elderly people. Indeed there is a need 
for further research into the risk factors for OSAHS in the elderly. (Young, 
Shahar et al. 2002)  
There may be a genetic component to sleep apnoea, and studies in a Scottish 
population provided evidence of a familial component to OSAHS, even with 
obesity excluded as a factor. (Mathur, Douglas 1995) There is also evidence that 
obesity itself can be familial. (Stunkard, Sorensen et al. 1986)  
Some studies have found that neck circumference, especially when adjusted for 
height, is a good prospective indicator for OSAHS in adults, with values less than 
37 cm and greater than 48 cm being strong predictors for low and high risk 
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1991, Davies, Ali et al. 1992, Hoffstein, Mateika 1992) In children, the major risk 
factor for OSAHS is adenoidal-tonsillar hypertrophy. (Marcus 2001) 
Racial origin may be a factor, with African Americans, Mexican Americans, 
Pacific Islanders, and East Asians having an increased incidence of OSAHS. 
(Schmidt-Nowara, Coultas et al. 1990, Redline, Kump et al. 1994, Li, Kushida et 
al. 2000) Several studies have shown that sleep disordered breathing is 
exacerbated by alcohol ingestion, especially around bedtime. (Taasan, Block et 
al. 1981, Scrima, Broudy et al. 1982, Krol, Knuth et al. 1984) Alcohol reduces the 
activity of the genioglossus muscle and can therefore predispose to upper airway 
collapse and apnoeas. (Krol, Knuth et al. 1984) It is not clear from the literature 
how much alcohol is required to reduce the activity of the muscles of the tongue 
and soft palate which are the main structures relevant to OSAHS. 
OSAHS may be exacerbated by sedatives, sleep deprivation, and a supine 
posture. (Mendelson, Garnett et al. 1981, Dolly, Block 1982, Roth, Roehrs et al. 
1985)  Respiratory allergies and nasal congestion may also increase OSAHS.  
In addition, disorders that impair sensory function and delay adjustment to 
abnormal airway narrowing (such as type 1 diabetes, chronic uraemia, 
dysautonomia) can cause and even worsen OSAHS. (Guilleminault, Mondini et al. 
1984, Mondini, Guilleminault 1985, Resnick, Redline et al. 2003)  
Of particular interest to dentists is the association between a number of 
craniofacial features and an increased risk of OSAHS. Jamieson et al (1986) 
investigated cephalometric values in 155 patients with sleep apnoea and 
compared them to 41 normal control patients. (Jamieson, Guilleminault et al. 
1986) They found a number of characteristics in patients with OSAHS including: 
retro position of the mandible, an acute nasion-sella-basion angle, and a 
displacement of the hyoid bone to a lower position than expected. These 
combined changes reduced the space occupied by soft tissues anchored on the 
skull and mandible, and the length of the soft palate was increased. (Jamieson, 
Guilleminault et al. 1986) This investigation led to numerous studies which, in 
general, have found that the following characteristics are more prevalent in 
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•  a high and narrow hard palate,  
•  an elongated soft palate,  
•  retrognathia with associated increased overjet. (Seto, Gotsopoulos et al. 
2001)  
A recent case control study corroborated the above findings with statistically 
significant differences between OSAHS patients and case matched controls for: 
maxillary and mandibular reduction in length, a significant (3.1mm) reduction in 
inter-maxillary space, a narrower nasopharyngeal airway and increased tongue 
size, and soft palate length and thickness. (Johal, Patel et al. 2007) 
There are reports in the literature of syndromic patients suffering from OSAHS 
more than normal individuals. These include patients with Treacher Collins 
Syndrome and clefts of the lip and palate. (Colmenero, Esteban et al. 1991)  
If a patient has a narrowed airway they are more likely to be at risk of OSAHS. It 
has been shown that patients with OSAHS have narrowed upper airways, even 
during wakefulness, as revealed by multiple imaging modalities, including 
computed tomography (CT) and magnetic resonance imaging (MRI). (Ahmed, 
Schwab 2006) The upper airway is not only smaller in patients with OSAHS but 
also more collapsible. (Horner, Shea et al. 1989, Gleadhill, Schwartz et al. 1991) 
The airway narrowing is more commonly found in the retro-palatal and retro-
glossal regions of the pharynx.  It has also been shown that the volume of upper 
airway soft tissue structures (tongue, lateral pharyngeal walls, soft palate, and 
para-pharyngeal fat pads) was significantly greater in patients with OSAHS than 
in normal subjects, even when other confounding factors were taken into 
account. (Schwab, Pasirstein et al. 2003, Schwab 2003)  
1.3.4 Pathogenesis of OSAHS 
Sleep apnoea is a slowly progressive disorder.(Peppard, Young et al. 2000) Most, 
if not all, apnoeas are caused by collapse of the pharyngeal airway. Pharyngeal 
patency depends critically on the action of upper airway dilator muscles, which 
contract during each inspiration to prevent the upper airway being closed by 
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tensor veli palatini), supra-hyoid muscles (genioglossus, geniohyoid) infra hyoid 
muscles (sternohyoid, sternothyroid) and laryngeal muscles (cricothyroid, and 
posterior cricoarytenoid.) (Lee-Chiong, Sateia et al. 2008) During sleep there is a 
reduction of activity of the upper airway dilator muscles, as well as a decrease 
in electromyogram (EMG) activity of genioglossus and tensor palatine, therefore 
predisposing to collapse. (Tangel, Mezzanotte et al. 1991, Tangel, Mezzanotte et 
al. 1992, Pack 2006) Muscle tone throughout the body decreases during sleep, 
with relaxation of the upper airway dilating muscles. In many individuals, this 
effect results in considerable upper airway narrowing during inspiration, which 
causes the turbulent flow and vibration of snoring. There are also changes in the 
upper airway that are likely to be secondary to the vibration produced by 
snoring and/or the large swings in intraluminal pressure during sleep. (Pack 
2006) These include denervation of soft palatal tissue in subjects with OSAHS 
and an inflammatory cell infiltrate in both the mucosal and muscle layers. 
(Friberg, Ansved et al. 1998, Boyd, Petrof et al. 2004) This has led to the 
concept of OSAHS being the progressive snorer’s disorder. (Friberg, Ansved et al. 
1998)  
In some individuals this upper airway narrowing may progress to produce 
clinically significant airway narrowing or occlusion which causes OSAHS. 
(Douglas, Polo 1994) 
1.3.5 Other causes of excessive daytime sleepiness  
The three main causes of excessive daytime sleepiness are insufficient duration 
of sleep, impaired quality of sleep, or hypersomnia. Sleep deprivation is the 
most common cause of excessive daytime sleepiness and is usually due to work 
or social pressures. (Shneerson 2005) 
Shift work can significantly disrupt sleep-wake patterns. Most individuals who 
present with this will be advised on sleep hygiene. (Shneerson 2005) Sleep 
hygiene can be defined as "all behavioural and environmental factors that 
precede sleep and may interfere with sleep."(van der Heijden, Smits et al. 2006) 
The main issues involved are sleep scheduling, use of stimulants, stimulating or 
upsetting activities too close to bedtime and an uncomfortable sleeping 
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The prevalence of excessive daytime somnolence is difficult to quantify due to 
the different criteria used and populations studied. The largest objective study 
included 740 day workers in Israel. The Epworth scale was used to assess 
sleepiness and it was found that 23% of the respondents had a score greater than 
10, indicating excessive sleepiness. (Melamed, Oksenberg 2002) The two main 
predictive factors associated with excessive sleepiness are full time employment 
and being single. Excessive sleepiness has also been correlated with severe 
depression and snoring episodes on more than 3 nights per week. (Hublin, Kaprio 
et al. 1996)  
The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire, which 
reflects the person’s general level of daytime sleepiness. (Johns 1991) It was 
designed to measure and quantify sleep inclination rather than fatigue, as 
manifested by the tendency to fall asleep in a variety of conditions. The 
maximum score is 24. The higher the score, the sleepier the patient, generally 
with scores up to 6–7 considered normal, 8–12 mild sleepiness, 13–17 moderate 
sleepiness, and 18 and above severe sleepiness. It is considered to be 
independent of short-term variations in sleepiness and the time of the day, and 
is consistent from day to day. It has been shown to be consistently higher in 
conditions associated with daytime somnolence (such as sleep apnoea, 
narcolepsy, idiopathic hypersomnolence), and normal in other sleep disturbances 
such as insomnia. However, again it reflects subjective assessment of sleepiness, 
without objective documentation. The ESS results correlate reasonably well with 
patient’s self ratings for overall sleepiness, but not well with Multiple Sleep 
Latency Test (MSLT) results. (Johns 1991, Johns 1994, Chervin, Aldrich et al. 
1997, Chervin, Aldrich 1999) For objective measurement of sleepiness, the 
Multiple Sleep Latency Test has been developed, with the working hypothesis 
that the drowsier the person, the more rapidly he or she should fall asleep under 
favourable conditions. (Lavie, Pillar et al. 2002) 
Impaired quality of sleep is the failure to sustain sleep or a stage of sleep 
because of frequent transitions to a lighter stage of sleep or to wakefulness. 
(Shneerson 2005) This can be due to external factors such as a noisy, light or 
uncomfortable temperature area in which to sleep. It can also be due to medical 
disorders including OSAHS, a motor disorder during sleep, gastro-oesophageal 
reflux, asthma, nocturnal angina, pain due to arthritis, neurological disorders Chapter 1        24 
and drugs. Stimulant drugs such as caffeine and amphetamines can cause 
arousals, tricyclic antidepressants may increase the frequency of limb 
movements, dopamine agonists can cause awakenings due to vivid dreams and 
alcohol and short acting hypnotics cause rebound insomnia at the end of the 
night. (Shneerson 2005) 
Other causes of excessive daytime sleepiness are circadian rhythm disorders, 
neurological disorders, systemic disorders and psychiatric disorders.  
1.3.6 Diagnosis of OSAHS 
Obstructive sleep apnoea is the most prevalent sleep disorder seen in diagnostic 
sleep laboratories world-wide, accounting for some 75–80% of the diagnoses. 
Central sleep apnoea is considerably less prevalent, except for specific patient 
populations, such as patients with chronic heart failure or patients with 
neurological disorders. Telephone based research in the UK of non-
institutionalised people found that sleep disordered breathing was under-
diagnosed. (Ohayon, Guilleminault et al. 1997) 
The diagnosis of OSAHS is ideally made when a person with daytime symptoms 
has significant sleep disordered breathing as shown  by polysomnography (study 
of sleep state, breathing, and oxygenation). Subjective clinical impressions of 
OSAHS tend to have inadequate sensitivity and specificity. (Viner, Szalai et al. 
1991, Hoffstein, Szalai 1993)Nocturnal pulse oximetry is widely used to screen 
for OSAHS, but polysomnography is the gold standard. The criteria for the 
diagnosis of significant sleep disordered breathing have not been rigorously 
assessed, but they have been set by a combination of consensus and convention. 
(Ross, Sheinhait et al. 2000) Diagnostic criteria for OSAHS have variable 
sensitivity and specificity. For example, an apnoea/hypopnoea index (AHI) of 
less than five is considered normal; however, people with upper airway 
resistance syndrome may have an AHI below five episodes per hour, and many 
healthy elderly people have an AHI greater than five. (National Commission on 
Sleep Disorders Research 1992, Guilleminault, Stoohs et al. 1993) In an effort to 
achieve international consensus, criteria have been proposed by The Report of 
an American Academy of Sleep Medicine Task Force (1999). (American Academy 
of Sleep Medicine Task Force 1999) and these criteria are becoming more widely 
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The severity of OSAHS can be classified according to two factors: daytime 
sleepiness and AHI. Severe OSAHS is defined as severe sleep disordered breathing 
(AHI > 35 episodes per hour) plus symptoms of excessive daytime sleepiness 
(such as Epworth Sleepiness Scale > 10.) In Scotland, the SIGN guidelines classify 
OSAHS by AHI: 5-14/hr is mild, 15-30/hr is moderate, and >30/hr is severe. 
(Scottish Intercollegiate Guidelines Network 2003) It is emphasised that these 
arbitrary units act as a guide only and each case must be evaluated on its own 
merits taking into account signs and symptoms as well as other related factors 
such as age. (Scottish Intercollegiate Guidelines Network 2003)  
The main features of OSAHS are excessive daytime sleepiness, impaired 
concentration, snoring, un-refreshing sleep, choking episodes during sleep, 
witnessed apnoeas, restless sleep, irritability/personality change, nocturia, and 
decreased libido. (Scottish Intercollegiate Guidelines Network 2003) Patients 
who have clinically significant sleep apnoea classically have an AHI in the 
moderate range, excessive daytime sleepiness and at least two other symptoms, 
some of which may need to be elicited from the partner of the patient. Certain 
ENT problems can cause some of the symptoms of OSAHS, and if this is 
suspected, early evaluation of these is recommended, especially if the patient’s 
symptoms are of rapid onset.  
Subjective assessment of OSAHS involves questioning both the patient and 
patient’s partner to evaluate their symptoms. Several questionnaires have been 
proposed to evaluate the likelihood of a patient suffering from OSAHS with 
varying accuracy. (Stradling, Crosby 1991, Partinen, Telakivi et al. 1988, 
Douglass, Bornstein et al. 1994, Sweere, Kerkhof et al. 1998, Netzer, Stoohs et 
al. 1999, Hersberger, Renggli et al. 2006)  
Other questionnaires are used to assess sleepiness, the two main ones are the 
Stanford Sleepiness Scale (SSS) and the Epworth Sleepiness Scale (ESS). (Johns 
1991, Johns 1994, Hoddes, Zarcone et al. 1973, Richardson, Carskadon et al. 
1978) The Epworth is the most commonly used questionnaire in UK sleep clinics 
and for research purposes. The Stanford Sleepiness Scale represents the 
sleepiness at a given moment, and changes on a moment-by-moment basis 
according to the circumstances. The scale ranges between 1 and 7, and 
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their state of sleepiness. The SSS is good for monitoring an individual patient’s 
progress, but is less suitable for comparing between patients.  
There are also some home monitoring systems suggested for the diagnosis of 
OSAHS. Ambulatory devices have initially included oximetry alone, but other 
methods of home monitoring, including a variety of recorded channels such as 
breathing effort and airflow, body movements and peripheral arterial tone, are 
also used. Some centres use split night studies, with CPAP titration for the 
second half of the night, the authors state these can be beneficial in some 
cases. (McArdle, Grove et al. 2000) Studies have also reported that limited sleep 
studies may be useful to reduce costs and technician’s time. (Johnson, Carter et 
al. 2004) 
1.3.7 Sleep apnoea – screening 
It is estimated that 93% of women and 82% of men with moderate to severe sleep 
apnoea are undiagnosed and there is recognition that sleep services cannot, at 
present, arrange sleep studies for each patient, therefore there is a justifiable 
need for a valid screening tool. (Scottish Intercollegiate Guidelines Network 
2003, Young, Evans et al. 1997, Harding 2001) In addition, elderly or infirm 
patients may find overnight studies in a hospital environment distressing and the 
equipment uncomfortable. 
Some studies have found Epworth sleep scores to be higher in patients with sleep 
apnoea (mean 13.2) than chronic snorers (mean 7.5.) (Chung 2000/11) Others 
have found no correlation between Epworth scores and AHI. (Osman, Osborne et 
al. 1999) Therefore excessive sleepiness is very sensitive for sleep apnoea but 
not specific, as sleep deprivation from other causes can also give high Epworth 
scores.  
One clinical study found a statistically significant correlation between the 
modified Mallampati score and the Respiratory Disturbance Index (RDI). The 
Mallampati score was devised by anaesthetists to estimate the size of the upper 
airway and therefore the ease of intubation. (Mallampati, Gatt et al. 1985a) The 
RDI is similar to the AHI, however, it also includes respiratory events which are 
not apnoeas or hypopnoeas but do disrupt sleep. The same group also found that 
tonsil size and BMI were statistically significantly correlated with RDI. Chapter 1        27 
(Friedman, Tanyeri et al. 1999) Another study found that the Mallampati score 
was only statistically significantly associated with OSAHS if the patient also has 
nasal obstruction. (Liistro, Rombaux et al. 2003) 
As was previously mentioned a BMI of at least 25kg/m
2 has been shown to have a 
sensitivity of 93% and a specificity of 74% for OSAHS. (Grunstein, Wilcox et al. 
1993) Although clinicians can use questionnaires, BMI, and neck circumference to 
help distinguish if a patient has OSAHS, the evidence suggests that clinical 
impressions alone are not sufficient for the screening of OSAHS. (Viner, Szalai et 
al. 1991)  
Different surveys and formulae have been used to distinguish patients with sleep 
apnoea from either patients with another sleep disorder or normal patients. The 
results range from 40% to 99% sensitivity and 28% to 100% specificity. (Viner, 
Szalai et al. 1991, Netzer, Stoohs et al. 1999, Maislin, Pack et al. 1995, Kushida, 
Efron et al. 1997, Kirby, Eng et al. 1999, Dixon, Schachter et al. 2003) Recent 
reviews of the literature highlight the need for further validation of these 
methods before widespread use is implemented. (Pang, Terris 2006) 
The Kushida Index is one of the above-mentioned screening methods and is 
potentially of interest to dentists. (Kushida, Efron et al. 1997) This index was not 
the first to attempt to predict whether a patient has OSAHS, but it was the first 
to take into account the craniofacial characteristics which are related to OSAHS. 
(Rojewski, Schuller et al. 1982, Rivlin, Hoffstein et al. 1984, Lowe, Santamaria 
et al. 1986, Ferguson, Ono et al. 1995) The test was formulated on 30 subjects, 
15 with a diagnosis of OSAHS and 15 without. In Kushida’s study, patient’s BMI, 
neck circumference, and some oral cavity measurements were used. Oral cavity 
measurements included palatal height, maxillary inter-molar distance, 
mandibular inter-molar distance, and overjet in millimetres. 
Kushida’s equation was established as follows:  
Equation 1- Kushida Index 
{P + (Mx - Mn) + 3 x OJ} + 3 x [Max (BMI – 25,0)] x (NC / BMI) 
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P is palatal height (in millimetres), or the distance from the dorsum of the 
tongue at the median lingual sulcus to the highest point of the palate, measured 
with the tongue in a relaxed position and the maxillary and mandibular incisor 
tips subtending an angle of 20 degrees from the mandibular condyle. 
Mx is the maxillary inter-molar distance (in millimetres) between the mesial 
surfaces of the crowns of the maxillary second molars.  
Mn is the mandibular inter-molar distance (in millimetres) between the mesial 
surfaces of the crowns of the mandibular second molars.  
OJ is the overjet (in millimetres), or the horizontal overlap of the crowns of the 
maxillary and mandibular right central incisors.  
BMI is the body mass index (in kg/m
2) 
NC is neck circumference (in centimetres) measured at the level of the 
cricothyroid membrane.  
The area of the formula in bold reflects the contribution of craniofacial 
dysmorphism, as measured from the oral cavity, to the prediction of OSAHS. The 
normal area reflects the contribution of obesity, as measured by BMI and neck 
circumference, to the prediction of OSAHS. The fraction NC ÷ BMI was selected 
to scale neck circumference relative to body size. The segment of the model 
enclosed within square brackets is limited to the larger of the two quantities: 
BMI –25, or zero. For example, if BMI is 25 or less, then [Max (BMI –25, 0)] is zero: 
That is, if BMI is 23, then (23 –25) = –2 and, because 0 is greater than –2, the 
maximum is zero. Therefore, if a patient is not obese (BMI≤25), the contribution 
of the second part of the model to the final index value is nil; the final index 
value reflects only the degree of craniofacial dysmorphism.  
Kushida et al (1997) conducted a prospective study of 423 patients, 300 of whom 
underwent polysomnography. Using their cut off value of 70 for the Kushida 
index, they found the means (±SD) for the OSAHS and non-OSAHS groups were 
95.3 ± 21.2 and 61.6 ± 6.2, respectively. The sensitivity (248 of 254) was 97.6% 
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positive predictive value (248 of 248) was 100% (CI, 98.5% to 100%), and the 
negative predictive value (46 of 52) was 88.5% (CI, 77% to 96%). The test also 
had good inter-examiner reliability of 99.2% and the estimated degree of error 
was a maximum of 4%. 
This morphometric model missed cases of OSAS in only six patients; that is, it 
gave six false-negative results. However, the mean calculated result was 67.3 ± 
3.3 for these six patients, which was close to the separation value of 70. In 
addition, the mean RDI for the six patients was low at 7.4 ± 3.1 (range: 5.3 to 
13.5). Thus, Kushida et al advised that values below but near the cut-off of 70 
(for example, between 65 and 70) should be interpreted with caution. 
The criteria for a diagnosis of OSAHS used by Kushida in 1997 was excessive 
sleepiness measured by Epworth >10, excessive daytime sleepiness, witnessed 
apnoeas and a RDI of 5 or more. As previously mentioned, current guidelines 
would classify a patient with an RDI of less than 10 as normal. (Scottish 
Intercollegiate Guidelines Network 2003) 
In 2004, Soares et al evaluated the Kushida index to assess its clinical 
acceptability and whether it was possible to distinguish OSAHS severity. (Soares, 
de Azeredo Bittencourt et al. 2006) They recruited 80 patients, but there was no 
randomisation in the selection process, instead they selected 20 mild OSAHS, 20 
with moderate OSAHS, 20 with severe OSAHS and 20 normal patients. All 
patients had undergone polysomnography. There was a higher percentage of 
men than women (approximately 2:1) which would account for more patients 
with OSAHS. They concluded that it was not possible to classify patients with 
OSAHS according to severity. However, this conclusion is not valid as the cut off 
value of 70 suggested by Kushida et al would not have identified the mean value 
for those patients with mild, moderate or severe OSAHS. 
One other group has used the Kushida Index. (Jung, Cho et al. 2004) They 
compared it to acoustic pharyngometry for the evaluation of the upper airway in 
patients with and without OSAHS. This group reported that the Kushida Index 
had a sensitivity of 89% (48 of 54) and a specificity of 94% (15 of 16) for the 
diagnosis of OSAHS. The authors reported that acoustic pharyngometry had a 
better sensitivity and specificity in their study (93% and 94%) than the Kushida Chapter 1        30 
Index (89% and 94%). They also used the cut off value of 70 for the Kushida 
Index. This study had a significant difference in the number of subjects recruited 
without OSHAS (16) in comparison to those with OSAHS (54). In addition, there 
was no evidence of a power calculation to determine sample size or of blinding 
of the assessors.  
It is apparent that further analysis of the Kushida Index is required before it 
could be recommended as a useful clinical screening tool. 
1.3.8 Treatment of sleep apnoea 
There are various approaches to the treatment of OSAHS and these can be 
categorised into behavioural, mechanical, pharmacological, and surgical.  
Behaviour change is difficult to achieve but can be very effective. Weight loss 
can be curative and even modest weight loss (10%) can relieve mild sleep 
apnoea. (Peppard, Young et al. 2000, Schwartz, Gold et al. 1991) All obese 
patients should be counselled about weight loss, but unfortunately this takes 
time and compliance may be low.  
Smokers have a higher incidence of respiratory problems than non-smokers and 
nicotine disturbs sleep patterns, so smoking cessation advice should be given to 
all smokers. (Phillips, Danner 1995) 
Airway tone can be reduced if patients take muscle relaxants, including alcohol 
and sedatives. This reduction in airway tone can prolong apnoeas and increase 
the arousal threshold. Patients should be advised of this and encouraged to 
reduce alcohol consumption. (Young, Skatrud et al. 2004)  
Patients of a normal weight and with mild disease may benefit from lying on 
their side rather than in a supine position. Studies have shown that upper airway 
dimensions, airflow resistance and airway collapsibility, all deteriorate in the 
supine posture, and have shown that change in sleeping posture is effective for 
the treatment of mild sleep apnoea. (Oksenberg, Silverberg 1998) 
Continuous positive airway pressure (CPAP) is a mechanical therapy developed 
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H2O through a nasal or oro-nasal mask. (Figure 1.2) CPAP pneumatically splints 
the entire airway and increases the functional residual capacity, may increase 
pharyngeal dilator activity, and reduces after-load on the heart. (Patel, White et 
al. 2003) During sleep, the tongue and soft palate lie against the posterior oro-
pharyngeal wall and CPAP prevents this, keeping the airway open. (Strohl, 
Redline 1986) 
 
Figure 1.2 CPAP Mask 
 
In 2002 the benefit of CPAP in patients with hypertension was shown in a 
randomised trial. (Pepperell, Ramdassingh-Dow et al. 2002) In that study, 118 
OSAHS patients with an average oxygen desaturation index (ODI) of 37 per hour 
were randomized to either CPAP, or sub-therapeutic CPAP for 4 weeks. The 
mean ambulatory arterial blood pressure dropped by 2.4mmHg during sleep and 
3.4 mmHg whilst awake in the CPAP group, and an increase of 0.8mmHg for the 
control group. The most severe OSAHS patient had the largest decrease in blood 
pressure. The significance of this finding may be seen when it is pointed out that 
small blood pressure decreases, in the region of 5mmHg, have been shown in a 
prospective long term study of 420,000 people to lessen the incidence of stroke 
by 34% and coronary heart disease by 21%. (MacMahon, Peto et al. 1990) 
After a diagnosis of sleep apnoea has been made during the first half of a sleep 
study, the titration of the CPAP air flow can be carried out in the second half. 
Auto-titration machines are now available which respond to the vibration of Chapter 1        32 
upper airway tissues or measure airflow and modify air pressure appropriately. 
(Littner, Hirshkowitz et al. 2002, Massie, McArdle et al. 2003) 
Compliance with CPAP is the major problem with its use. It is estimated that 
only 50-60% of patients will use the machine on a regular basis. (Kribbs, Pack et 
al. 1993, McArdle, Devereux et al. 1999, Janson, Noges et al. 2000)   
The adverse effects of CPAP are frequent, with some studies reporting 96% of 
patients having at least one side effect, although many of these are minor. 
(Kalan, Kenyon et al. 1999) The side-effects can be due to the nasal mask, to 
local intra-nasal adverse effects, or to problems due to the noise and bulk of the 
machine. Major side effects of CPAP are rare (such as significant epistaxis, 
paranasal sinusitis), but minor side effects (including, rhinitis, nasal bridge 
sores, discomfort and noise) have been frequently reported. (Kalan, Kenyon et 
al. 1999, Pepin, Leger et al. 1995) Some patients may suffer from rhinitis and 
intranasal corticosteroid therapy may improve their sleep apnoea, but not 
necessarily their sleep quality or snoring. (Kiely, Nolan et al. 2004) A financial 
disadvantage of CPAP is the high cost of the machine and maintenance. (NHS 
Quality Improvement Scotland 2008) 
The benefits of CPAP are that it can reduce mortality, frequency of automobile 
accidents, hypertension and other cardiovascular diseases, cognitive 
impairment, sleepiness, healthcare costs, impaired quality of life, depression 
and impotence. (Wright, Johns et al. 1997, Peker, Hedner et al. 2002, Pepperell, 
Ramdassingh-Dow et al. 2002, He, Kryger et al. 1988, Engleman, Martin et al. 
1994, Karacan, Karatas 1995, Whittle, Finch et al. 1997, Jenkinson, Davies et al. 
1999, Bahammam, Delaive et al. 1999, Hack, Davies et al. 2000, Bardwell, 
Ancoli-Israel et al. 2001, Means, Lichstein et al. 2003, Becker, Jerrentrup et al. 
2003) 
Supplemental oxygen improves overall oxygenation during sleep in patients with 
OSAHS but increases apnoea duration while reducing apnoea frequency only 
slightly. (Martin, Sanders et al. 1982, Gold, Schwartz et al. 1986) Daytime 
sleepiness is not reduced. Therefore, in most instances supplemental oxygen 
alone is not sufficient for treating OSAHS. (Ryan 2005) Chapter 1        33 
A number of surgical procedures have been used in the treatment of OSAHS 
including: Tracheotomy, Uvulopalatopharyngoplasty (UPPP), Laser-assisted 
Uvulopalatopharyngoplasty (LAUP), septoplasty, maxillofacial surgery, 
radiofrequency volumetric tissue reduction (somnoplasty), and recently soft 
palate implants. 
Uvulopalatopharyngoplasty (UPPP) is the most commonly used and researched 
form of surgical treatment for OSAHS. It involves enlargement of the retro-
palatal airway by excision of any enlarged tonsils, trimming and reorientation of 
the posterior and anterior tonsillar pillars, and excision of the uvula and 
posterior portion of the palate. Sher’s review (2002) concluded that UPPP results 
in a mean decrease of 55% in the AHI and a mean decrease of RDI of 38% and the 
success rate of UPPP is about 50%. (Sher 2002) Complications include 
velopharyngeal insufficiency (2%), post-operative bleeding (1%), nasopharyngeal 
stenosis (1%), voice changes (1%), foreign body sensation (0.2%) and in rare 
circumstances death can occur. The incidence of complications is difficult to 
accurately calculate as many studies do not report the complications. (Sher, 
Schechtman et al. 1996/2) 
Dramatic improvements have been reported with surgical weight loss, although 
on long-term follow-up of patients undergoing gastric reduction surgery, a 
recurrence of substantial apnoea has been observed in some, despite only 
minimal weight gain. A systematic review and meta analysis found that following 
bariatric surgery, OSAHS had resolved in 85.7% of patients. (Buchwald, Avidor et 
al. 2004)  
Soft palate implants for snoring were not recommended for clinical use until 
further research was carried out, and in a separate NICE guidance document, 
they are not currently used for sleep apnoea due to inadequate evidence and the 
serious nature of sleep apnoea. (National Institute for Health and Clinical 
Excellence (NICE) 2007a) 
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1.4 Upper Airways resistance syndrome 
The term “upper airways resistance syndrome” (UARS) was first introduced in 
1992, and applies to people who have impaired respiration during sleep but do 
not fit the typical diagnosis of OSAHS. (Guilleminault, Stoohs et al. 1992) The 
patients typically snore, have daytime sleepiness but no clear signs of apnoeas, 
hypopnoeas, or oxygen desaturations. It is a controversial term, not used by all, 
and the second edition of the International Classification of Sleep Disorders 
(ICSD-2) incorporated it under OSAHS as it was felt that the pathophysiology 
does not differ significantly from that of OSAHS. (Duchna 2006) 
1.5 Oral Appliances 
Pierre Robin (1902) first published his work on the “monobloc” device for the 
treatment of glossoptosis, and then later used this type of appliance to 
reposition the mandible. (Robin 1902, Robin 1934) The first report of the use of 
surgical mandibular advancement for a sleep disorder was in 1980. (Bear, Priest 
1980) This work was taken forward for non-surgical management by using tongue 
retaining devices. (Cartwright, Samelson 1982) 
1.5.1 Oral appliance types and features 
Three types of oral appliance can be used for treating snoring and sleep apnoea; 
these are soft palate lifters, tongue retaining devices, and mandibular 
advancement appliances.  
1.5.2 Soft palate lifters 
Soft palate lifters (Figure 1.3) have been used for treating snoring, however due 
to gagging problems and their ineffectiveness, they are no longer used for sleep 
disorders. In addition, they could only work if the site of snoring was the soft 
palate.(Paskow 1987, Wagner, Price 1987, Paskow, Paskow 1993, Marklund, 
Franklin 1996, Barthlen, Brown et al. 2000) Currently they are only used for 
patients with soft palate incompetence after referral from a speech therapist. 
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Figure 1.3 Soft Palate Lifter Appliance 
1.5.3 Tongue retaining devices 
Tongue retaining devices reposition the tongue in an anterior position by 
securing it with suction in a soft plastic bulb or with a resin depressor that 
comes into direct contact with the base of the tongue. (Figure 1.4 This was the 
first type of oral appliance described for treating sleep disorders. In a study of 
20 patients, 3 could not tolerate the appliance, but for the remainder there was 
a reduction in apnoeas. (Cartwright, Samelson 1982) The one credible advantage 
of these appliances over mandibular advancement appliances is that they can be 
used for edentulous patients. However, they are unsightly, require nasal 
breathing, can cause tongue irritation and are less effective than mandibular 
advancement appliances. (Barthlen, Brown et al. 2000) 
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1.5.4 Mandibular advancement appliances 
Mandibular advancement appliances (also called mandibular advancement 
devices) are now the most widely used oral appliances for sleep disordered 
breathing. (Figure 1.5) 
The mandibular advancement appliances are either a one-piece, or a two-piece 
design and can be either prefabricated  or custom-made (Eckhart 1998) The pre-
fabricated appliances generally are constructed of a thermolabile material which 
is warmed and moulded by the individual, a so called “boil and bite” appliance. 
The custom made appliances are generally constructed by a dentist via 
impression making, jaw registration and then fabrication in a dental laboratory. 
(Lindman, Bondemark 2001) It has been suggested that the thermolabile 
preformed appliances could reduce costs and predict success with a custom-
made appliance. (Schonhofer, Hochban et al. 2000, Maurer, Huber et al. 
2007)The suggestions are based only on opinion and a recent randomized 
controlled cross-over trial has shown that the custom-made appliances are 
superior to the pre-formed appliances in terms of reduction in snoring and 
apnoeas. (Vanderveken, Devolder et al. 2008)  Also, it is clear that failure with a 
pre-formed appliance does not mean that failure will occur with a custom made 
appliance, simply because retention is considerably better in a custom-made 
device.  
The appliances can have partial or full occlusal coverage. They may be 
constructed using a soft or hard material and some permit jaw movement. It is 
also possible to provide adjustment of protrusion to provide maximum relief of 
symptoms with minimal side effects.  
In bruxists, it is advised that a flexible two piece design is used to permit lateral 
movement. (Henke, Frantz et al. 2000, Sjoholm, Lowe et al. 2000)  
There is no robust evidence that a two-piece design appliance is better than a 
one piece designed appliance for the treatment of OSAHS. (George 2001)  
There is some debate over the amount of jaw opening provided by the 
appliance, as too much opening increases the chance of posterior displacement 
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patency by stretching palatoglossus and the superior pharyngeal constrictor 
muscles. (George 2001) One randomized controlled crossover study (Pitsis, 
Darendeliler et al. 2002) compared appliances which provided 4mm and 14mm of 
jaw opening. Although there was no difference in efficacy in the short term of 
the study, 78 % of patients preferred the appliance with less increase in vertical 
dimension.  
 
Figure 1.5 Mandibular Advancement Appliance 
 
The obstruction of the airway in sleep apnoea is most likely due to a 
combination of abnormal anatomy and abnormal physiology. (Schwab 2003, 
Strohl 2003)  Cephalometric studies on awake patients, in both upright and 
supine positions, have demonstrated that anterior repositioning of the mandible 
increases the posterior airway space and sagittal cross sectional area of the 
pharynx. (Schmidt-Nowara, Meade et al. 1991a, Ishida, Inoue et al. 1998, Liu, 
Park et al. 2000) Computerised tomography and videoendoscopy studies on 
awake supine patients have also shown an increase in the pharyngeal cross 
sectional airway size and velopharynx size when using a mandibular 
advancement appliance. (Ryan, Love et al. 1999, Gale, Sawyer et al. 2000) 
Magnetic resonance imaging studies both in the asleep and awake patient in a 
supine position have shown increased area in the nasopharnyx, oropharynx, and 
hypopharynx with a mandibular advancement appliance. (Ishida, Inoue et al. 
1998, Gao, Zeng et al. 1999)Therefore there is a large body of evidence that has 
shown that advancing the mandible can enlarge the airway and reduce 
collapsibility. (Ryan, Love et al. 1999, Gale, Sawyer et al. 2000, Kato, Isono et 
al. 2000, Hiyama, Tsuiki et al. 2003, Ng, Gotsopoulos et al. 2003, Battagel, Johal 
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Mandibular advancement appliances are reported to reduce snoring by 73% to 
100%. (Schmidt-Nowara, Lowe et al. 1995) It is also clear that these appliances 
improve snoring according to bed partners and this is probably the most relevant 
outcome measure. (Bonham, Currier et al. 1988, Cameron, Lyons et al. 1998, 
Lyons, Cameron et al. 2001) A recent review, which included 18 studies and 529 
patients, found that no matter what outcome measure was used, mandibular 
advancement appliances were successful in reducing snoring. (Hoffstein 2006) 
Hoffstein (2006) reviewed the evidence on the efficacy of oral appliances for the 
treatment of sleep apnoea. He classified success as an AHI less than 10 with the 
appliance in place. He classified response rates as the percentage of patients in 
whom the AHI, with the appliance in place, was greater than 10 but less than 
50% of the baseline value. Using these definitions, he found that 21% of 1577 
patients from 51 studies had a 50% reduction in AHI (response rate) and 54% of 
2087 patients from 59 studies had an AHI less than 10 (success rate.) (Hoffstein 
2006) Only five randomised, crossover, controlled studies of the efficacy of oral 
appliances have been reported. (Hoffstein 2006, Mehta, Qian et al. 2001, 
Johnston, Gleadhill et al. 2002, Gotsopoulos, Chen et al. 2002, Barnes, McEvoy 
et al. 2004, Naismith, Winter et al. 2005) Four used a control (non active) 
appliance and one used a drug placebo. In 270 patients with mild to moderate 
sleep apnoea, the success rate was 50% and response rate was 14%. 
A recent Cochrane review highlighted six studies that compared a control 
appliance which did not advance the mandible to oral appliances which did 
advance the mandible for the treatment of sleep apnoea. (Johnston, Gleadhill et 
al. 2002, Gotsopoulos, Chen et al. 2002, Hans, Nelson et al. 1997, Duran, 
Esnaola et al. 2002, Engleman, McDonald et al. 2002, Blanco, Zamarron et al. 
2005, Lim, Lasserson et al. 2006) This review showed that when the results were 
pooled, a 15.5 point decrease in AHI was observed with the active appliance. 
(Lim, Lasserson et al. 2006) 
The same review reported that CPAP was more effective than oral appliance 
therapy. Nine studies compared an oral appliance to CPAP. Contacting authors 
allowed additional data to be obtained for seven of these studies. A 7.97 AHI 
difference between CPAP and oral appliances in favour of CPAP was observed. 
(Barnes, McEvoy et al. 2004, Engleman, McDonald et al. 2002, Lim, Lasserson et Chapter 1        39 
al. 2006, Ferguson, Ono et al. 1996, Ferguson, Ono et al. 1997, Olson, 
Ambrogetti et al. 2002, Tan, L'Estrange et al. 2002, Randerath, Heise et al. 
2002)  
In Hoffstein’s meta-analysis (Hoffstein 2006), 232 patients from seven studies 
compared CPAP and oral appliances, and found that AHI with an oral appliance 
remained at 14, whereas AHI with CPAP was 6. However, patients in general 
preferred the oral appliance to CPAP.  
It would be beneficial if clinicians were able to predict who would respond 
favourably to an oral appliance, yet despite ongoing research there are no 
robust criteria. As there is a biological plausibility that patients with retro-
glossal collapse, as opposed to velopharyngeal collapse, would have a greater 
chance of success with a mandibular advancement appliance it would seem 
sensible to recommend oral appliances for this group of patients. The only study 
which has investigated the success of mandibular advancement appliances in 
both types of patients found that those with retro-glossal collapse benefited 
more than those with velopharngeal collapse.  However, the study only included 
four patients with retro-glossal collapse and eight with velopharyngeal collapse. 
(Ng, Qian et al. 2006) 
1.5.5 Side effects of oral appliances 
The side effects most commonly reported are dry mouth, excessive salivation, 
discomfort, occlusal changes, headaches and temporomandibular joint 
discomfort. (Schmidt-Nowara, Meade et al. 1991a, Cameron, Lyons et al. 1998, 
Clark, Arand et al. 1993, Eveloff, Rosenberg et al. 1994, O'Sullivan, Hillman et 
al. 1995, Shadaba, Battagel et al. 2000, Fritsch, Iseli et al. 2001, McGown, 
Makker et al. 2001, Walker-Engstrom, Ringqvist et al. 2003, Marklund, Stenlund 
et al. 2004, Dort, Hussein 2004)  
Occlusal changes involving a 2-4mm reduction in overbite and overjet following 
use of the appliance have been reported. If data from studies which analysed 
tooth movement are amalgamated, there are 389 patients with a mean follow up 
of 39 months that showed a mean overbite reduction from 3.8 to 2.4 mm and a 
mean overjet reduction from 4.0 to 2.7mm. (Hoffstein 2006, Almeida, Lowe et 
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1.5.6 Compliance with oral appliances 
As most patients receive an appliance for mild sleep apnoea or chronic snoring, 
they may be less motivated to wear the appliance, even if the side effects are 
minimal, as the main complaint may be from the patient’s bed partner. If the 
bed partner was no longer present, or no longer complained of the snoring, the 
patient is unlikely to wear the appliance. (Hoffstein 2006)  
Compliance with mandibular advancement appliances has been reported to 
range from 4-76% at the end of one year. (Jauhar, Lyons et al. 2008a) Hoffstein 
(2006), who reviewed 21 studies with 3107 patients using mandibular 
advancement appliances, with longer term follow up of 33 months found 
compliance rates of 56-68%. (Hoffstein 2006) 
1.6 Summary 
Oral appliances have a good evidence base for treatment; however there is a 
need for long term follow up studies with patient centred outcomes. The role of 
the dentist in their management needs clarification.  
1.7 Aims 
The aim of this project is to examine the role of dentists in the management of 
snoring and sleep apnoea. The specific aims are three-fold: 
•  To assess the long–term success of mandibular advancement devices. 
•  To determine the views of dentists and sleep specialists on the 
involvement of dentists in these medical problems. 
•  To assess the value of a screening tool which shows potential for use by 
dentists to evaluate patients with snoring or OSAHS. 
 
 Chapter 2      41 
Chapter 2 - Long term follow-up of mandibular 
advancement appliances for the management of 
snoring and sleep apnoea 
2.1  Introduction 
Although oral appliances have been shown to be an effective treatment option, 
long term evidence of their tolerance is limited. Marklund et al 2004 carried out 
a prospective study on 619 patients who received mandibular advancement 
appliances from 1989 until 2000. (Marklund et al. 2004) The results show 76% of 
subjects complied with oral appliance treatment but there was limited 
information on patient based outcomes. One of the earlier UK studies involving 
mandibular advancement appliances was that of Cameron et al in 1998. 
(Cameron, Lyons et al. 1998, Lyons, Cameron et al. 2001, D. Sword, W. T. N. Lee 
et al. 2004) In this study, patients were seen by a consultant respiratory 
physician, provided with a mandibular advancement appliance and reviewed 
over a number of months. It was evident that the majority of patients that 
snored and that wore the appliance responded favourably. The results of the 
study indicated that 96.7% of patients had their snoring reduced or eliminated. 
What was unknown was how useful patients found these appliances over a longer 
period of time.  
2.2 Hypothesis 
The hypothesis was that Mandibular Advancement Appliances (MAA) are an 
acceptable form of treatment in the long term for patients with problem snoring 
and mild to moderate obstructive sleep apnoea. 
2.3 Material and Methods 
A questionnaire study was designed to follow up 180 patients who had been 
provided with appliances 10 years previously. Ethics Committee approval was 
obtained for the original trial in 1996 but was not required for this present 
service evaluation. (Personal communication from West of Scotland Ethics 
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The questionnaire was first piloted on current patients attending the clinic for 
construction of an MAA, then reviewed and finalised. (See Appendix) There were 
18 questions relating to the appliance, patients sleep quality and lifestyle. 
Patients were asked to give their weight and height (in either imperial or metric 
units) and whether they smoked and if so, the quantity. They were also asked 
how much alcohol they consumed, in units per week. A UK unit of alcohol is 10ml 
or 8 grams of pure alcohol (ethanol). As a guide, half a pint of 3.5% beer is 1 unit 
and 1 small glass (125 ml) of 9% wine is 1 unit. Sleep duration was simply 
recorded as hours per night on average and sleep quality as either “good”, 
“average” or “poor”. The effects of body mass index, alcohol consumption, 
sleep duration, and sleep quality on success were analyzed using chi-squared 
tests (α=.05). 
2.4 Results 
The 180 patients who were sent a questionnaire consisted of 150 males (83%) 
and 30 females (17%). The response rate was 40% with 72 replies, 56 males (78%) 
and females 16 (22%).  There was a varying degree of completion of data in each 
questionnaire returned. Two questionnaires were returned unopened as the 
patients had died. One other was returned as the patient had since moved and 
left no forwarding address. 
Section 1. The appliance. 
When asked “how many days/nights do you wear the appliance?”, the results 
showed that 47% of patients wear their appliance every night (Figure 2.1). 24 
patients indicated that they had abandoned wearing the device. 
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Figure 2.1 Number of nights appliance used. 
Of the 24 who had abandoned wearing the device, 12 found it ‘Very 
Uncomfortable’, 3 found it ‘Slightly Uncomfortable’, 2 found it ‘Comfortable’, 
and no data were available on the remaining 7. 
We asked the patients “How many hours per night/day do you wear it?” 56 
patients responded to this question. 60.7% stated that they wore the appliance 
for 7 hours or more. If those who wore the appliance for 6 hours are included, 
the percentage goes up to 75.0%. 
 
Figure 2.2 Number of hours a night appliance worn. Chapter 2      44 
As it is important that patients find the appliance comfortable we asked “How 
comfortable do you find it?”  71 patients responded to this question (Figure 2.3).  
 
Figure 2.3 Comfort of the appliance. 
 
The main outcome measure is whether the appliance helps their snoring so the 
patients were asked “Does the appliance affect your snoring?” The results are 
depicted in Figure 2.4.  
Figure 2.4 Effectiveness of appliance on snoring. 
There were 68 responses to this question. 7 gave no data and 15 stated that 
there was no improvement. 20 respondents indicated that there was a slight 
improvement and 26 stated that it was much better. 
Patients were also asked to assess their opinion of the appliance, “How satisfied 
are you with the appliance?” 39 out of 68 respondents indicated that they were Chapter 2      45 
very satisfied/ satisfied with the appliance, a satisfaction rate of 57.4%. There 
were 23 who were not satisfied with the appliance and no data on 6 replies. 
The results from Question 3 have been cross-tabulated (Table 2.1) with the 
results from Question 5. Those who found the device uncomfortable were not 
satisfied and vice versa. 
 
Table 2.1 Comfort tabled against satisfaction. 
 
  No 
Data 
Very 
Uncomfortable 
Slightly 
Uncomfortable 
Comfortable  Total 
No Data  6  0  0  0  6 
Very Satisfied  0  3  4  8  15 
Satisfied  0  2  16  6  24 
Not Satisfied  0  16  5  2  23 
Total  6  21  25  16  68 
 
The patients were also asked “Have you noticed any side effects?” 32 out of 68 
respondents stated that they had noticed a side effect (47%).  Those who 
indicated a side effect were asked to give details, these are summarised as 
follows (Table 2.2):- 
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Table 2.2 Side effects of the appliance. 
 
Side effect  Number 
Pain/discomfort   9 
Excessive salivation   2 
Dry mouth/ difficulty breathing if 
nose blocked  
2 
Loose   2 
Teeth more stained by bacteria.   1 
Lower jaw displaced. Caused 
problems when chewing food.  
1 
Repositioned jaw   1 
Excessive “wind”   1 
 
 
Section 2. Sleep Quality. 
Patients were asked “On average, how many hours do you sleep per night?” The 
results are shown in Figure 5. Slightly over 50% of respondents stated that they 
slept 7-9 hours per night. 
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Figure 2.5 Number of hours of sleep per night. 
 
68 patients replied to the next question “Do you feel more refreshed on waking 
when you wear the appliance than if you do not wear it?” 31 respondents stated 
that felt more refreshed, 45.6%. 28 said ‘No’ and 3 ‘Don’t know’, 45.6%. Data 
was not provided from a further 6 responses. 
Patients were also asked “Does wearing the appliance affect your level of 
sleepiness following sleep?”  65 responded, 30 (46.2%) were less sleepy; and 24 
(36.9%) said there was no effect; Data was not provided for 11(16.9%) patients. 
Patients were asked “Do you feel refreshed following your sleep?”  Of the 65 
that responded, 22 (33.8%) said Yes; 26 (40%) said Sometimes; and 11 (16.9%) 
said No; No data was provided for 6 (9.2%) patients. 
Taking the two positive responses together gives a total of 73.8%. 
Another question on sleep quality was “Do you feel sleepy during the day?”  66 
responded, of those 15 (22.7%) said Yes; 13 (19.7%) said No; 32 (48.5%) said 
Sometimes. There was no data provided for 6(9.1%). 
Patients were asked “Which position are you in when you snore? Tick all that 
apply.” The results of the 66 replies are shown in Figure 2.6. Supine was the 
most common position for snoring. 
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Figure 2.6 Position whilst snoring. 
  
Patients were also asked “How would you rate your quality of sleep?” There 
were 66 responses, 12 (18.2%) said their sleep quality was good, 34 (51.5%) said 
it was average, 14 (21.2%) said it was poor and there was no data provided for 6 
(9.1%).  
Patients were asked “Do you suffer from sleep apnoea and if so what is your 
category?” the results are shown in figure 2.7. 
Figure 2.7 Sleep apnoea severity. 
 
 
56.2% of respondents denied sleep apnoea or did not know. Over 1 in 8 (13.4%) 
claimed to suffer from severe sleep apnoea. 
Section 3 of the questionnaire was about the patients themselves. Chapter 2      49 
Patients were asked to submit details of height and weight in either imperial or 
metric units. 49 responded with both height and weight measurements. From 
this, the Body Mass Index (BMI) was recorded. 
Height varied from 5 feet to 6 feet four inches. Weight ranged from 8 stone to 
21 stone. 
BMI ranged from 21 to 45 with the mean at 30.18. The range of values for the 49 
responses are shown in Figure 2.8. 
 
Figure 2.8. BMI 
 
Patients were asked if they smoked, 66 replied with 8 smokers and 55 non-
smokers.  
Of the 8 that smoked, 3 smoked cigars/cheroots, and 5 smoked cigarettes. Two 
smoked 1-5 per day, one smoked 6-15 per day, and four smoked 15+ per day. No 
data from 1 respondent regarding type and number per day. 
There were 66 replies to the question on alcohol consumption, 53 (80.3%) drank 
alcohol and 10 (15.2%) did not. There was no information given for 3 patients. 
(Fig 2.9) 
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Figure 2.9 Number of units of alcohol per week. 
 
Patients were then asked, “How motivated are you to stop or reduce your 
snoring?” There were 63 responses to this question.  A minority, 3 (2.4%) said 
‘Not at all’; 19 (29.4%) said their ‘Partner was more concerned’; and 42 (66.6%) 
were ‘Very motivated'. There was no data provided for 1 patient (1.6%). 
The final question asked, “Overall, how would you rate the success of the 
appliance?”  There were 64 responses, with 29 (45.3%) stating the appliance was 
good, 15 (23.4%) stating it was fair, 19 (29.7%) stating it was poor, and 1 (1.6%) 
did not provide data. 
The following tables outline data examined for any links between success and 
the following factors: BMI (Table 2.3), smoking (Table 2.4), alcohol consumption 
(Table 2.5), sleep duration (Table 2.6) and sleep quality (Table 2.7). The only 
factor that showed a significant association with success was sleep quality 
(P=.027). 
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Table 2.3 Success tabled against BMI. 
 
BMI  21  23  26  27  28  29  30  31  32  33  34  35  36  37  39  44  45  Total 
Poor  0  0  4  1  0  3  0  1  1  1  1  1  1  1  0  0  1  16 
Fair  0  0  1  1  1  1  3  2  2  0  0  0  0  0  0  1  0  12 
Good  2  1  4  3  0  2  2  0  2  0  1  0  1  1  1  0  0  20 
Total  2  1  9  5  1  6  5  3  5  1  2  1  2  2  1  1  1  48 
Green shaded area = normal 
Orange shaded area = overweight 
Red shaded area = obese 
There is no apparent relationship. 
Table 2.4. Success tabled against Smoking. 
 
  Smoker  Non-Smoker  Total 
Poor  4  14  18 
Fair  0  15  15 
Good  4  25  29 
Total  8  54  63 
 
There are not enough smokers in the sample to provide significant conclusions. Chapter 2      52 
Table 2.5. Success tabled against Alcohol Consumption. 
 
  0-4 units  5-10 units  10 – 20   20 - 30  30 - 40  Total 
Poor  1  7  6  1  0  15 
Fair  2  3  4  2  3  14 
Good  4  9  7  4  0  24 
Total  7  19  17  7  3  53 
 
There does not appear to be a significant variation detected. 
Table 2.6. Success tabled against sleep duration. 
 
  0  1-3 hours  4-6 hours  7-9 hours  Total 
0  1  0  0  0  1 
Poor  1  3  7  7  18 
Fair  0  1  6  8  15 
Good  0  1  9  18  28 
Total  2  5  22  33  62 
 
 
 
 
 
 Chapter 2      53 
Table 2.7 Success tabled against sleep quality. 
 
  0  Poor   Average  Good  Total 
0  1  0  0  0  1 
Poor   1  6  8  1  16 
Fair  0  3  11  1  15 
Good  0  5  14  10  29 
Total  2  14  33  12  61 
 
Patients were then given the opportunity to make any other comment. 
A total of 59 comments were received, some more relevant than others. 
Generally speaking, 27 comments were positive, 10 were neutral and 18 were 
negative with frequencies in brackets where appropriate. 
Comments: 
Negative 
Loose (11) 
 Discomfort (4) 
“His snoring is a COMPLETE NIGHTMARE and that is with us sleeping in separate 
rooms and I have earplugs.” (wife) 
Neutral 
Now using CPAP (10) Chapter 2      54 
Lost appliance (1) 
“No difference” (1) 
Positive 
“Device is marvellous. A marriage saver” 
“I make less noise when I use the appliance” 
I only wear it when I am on holiday/staying with relatives/ have guests. My 
relatives tell me it works.” 
“It has made a big difference.” 
“My wife said it was good.” 
“The device is a life-saver. It needs to be replaced. It has made life bearable.” 
2.5 Discussion 
The response rate of 40% is in line with other previously published questionnaire 
studies on compliance with oral appliances for sleep disorders. (Almeida, Lowe 
et al. 2005)  A response rate of 40% may be considered good, considering that 
the patients attended 10 years ago and were not followed up specifically for 
their MAA. Other studies of patients’ satisfaction with dental treatment have 
found returns of questionnaires to vary between 30 and 40%. (Chapko, Bergner 
et al. 1985)The fact that 69% of respondents categorized the appliance as “fair” 
or “good” after 10 years is a remarkably high level of success.  
The use of these appliances is 67% (48), with 47.2% (34) wearing the appliance 
nightly (Figure 2.1). This is similar to the findings of McGowan, who found that 
68% used the appliance nightly. (McGowan, Makker et al. 2001) Of those that had 
stopped wearing the appliance, 24, 50% (12) had stated that it was very 
uncomfortable, which is the most likely reason for it not being worn.  Chapter 2      55 
As the disturbance to the partner has usually prompted the referral for 
treatment, then it can be assumed that patients would not wear the appliance if 
it was not effective. It is also unlikely that the patient would wear the appliance 
if they no longer have a partner or if the partner no longer complains about the 
snoring even if it was comfortable and effective. (Hoffstein 2006) 
In this present study, 75% reported wearing the appliance for 6 hours or more 
per night (Figure 2.2), which also is comparable to previously published data of 
an average usage of 6.6 hours per night. (McGown, Makker et al. 2001)  
The total number of patients that indicated some improvement in this study was 
67.6%. This is very good for a 10 year follow up and for limited expense to the 
health service and compares favourably with other studies, but is a reduction in 
efficacy from the initial published pilot study results (Schmidt-Nowara, Lowe et 
al. 1995, Cameron, Lyons et al. 1998). 
The reported side effects (Table 2.2) are broadly in agreement with published 
data and appear to be minor in nature. (Cameron, Lyons et al. 1998, Clark, 
Arand et al. 1993, Eveloff, Rosenberg et al. 1994, O'Sullivan, Hillman et al. 1995, 
McGown, Makker et al. 2001, Marklund, Stenlund et al. 2004) However, the 
reported discomfort of 9 out of 32 (28%) was lower than other published data, 
which ranged from 44.4%-52%. (McGown, Makker et al. 2001, Almeida, Lowe et 
al. 2005) 
Respondents self professed motivation to reduce or stop their snoring revealed 
22 out of 63 (35%) of patients stated they were not at all motivated or that their 
partner was more motivated than themselves. Clinical experience has shown 
that these individuals are less likely to succeed as they will give up on a 
treatment sooner than the more motivated patients.  
The majority of the comments (27 out of 59 comments (46%)) were positive, 
with some making qualitative statements about improvement in quality of life 
for both the patient and their partner.  
A high proportion of the patients were overweight (mean BMI over 30). A BMI of 
at least 25kg/m
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74% for OSAHS. (Grunstein, Wilcox et al. 1993) Obesity increases the rate of 
progression of the disease and weight gain further accelerates this process. 
(Peppard, Young et al. 2000) It is possible that some patient’s weight will have 
changed over the 10 years and this may explain the difference between the 
diagnosis at first presentation and the diagnosis 10 years later.  
There is some evidence that in the absence of other factors, mild to moderate 
sleep apnoea may worsen over time, therefore some of these patients may have 
a higher AHI now than when originally studied. However, another long term 
study looked at the AHI over time and found that those treated with a MAA did 
not have an increase in AHI and they hypothesised that this could be a direct 
result of wearing the appliance. (Marklund, Sahlin et al. 2001, Pendlebury, Pepin 
et al. 1997) 
It is a limitation of this present study that there was no specific follow-up of 
these patients after the first year of the study period and therefore there was no 
information on the number of appliances that had been replaced during that 
time. A further limitation is the lack of follow-up sleep study data, as it is 
possible that some patients’ AHI may have become higher during the 10 year 
study period. Further prospective long-term studies are required which include 
data from periodic sleep studies and regular (typically annual) review and 
replacement of appliances as required. 
2.6 Conclusions 
The results of this study tend to support the original hypothesis that the MAA is 
an acceptable form of treatment in the long term for patients with problem 
snoring and mild to moderate obstructive sleep apnoea based on patient based 
outcomes. It is clear that some patients will use this form of treatment for a 
long period of time even though they may not have received the motivation of 
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Chapter 3 - Dentists’ and doctors’ attitudes to the 
provision of intra-oral appliances for the 
management of snoring and sleep apnoea 
3.1 Introduction 
Intra-oral appliances were first used for the control of snoring and OSA in Canada 
and the USA in the late 1980’s and in the UK in the mid 1990’s. (Cameron, Lyons 
et al. 1998, Clark, Nakano 1989, Schmidt-Nowara, Meade et al. 1991b, Stradling, 
Negus et al. 1998) The increased availability of intra-oral appliances, almost 
exclusively mandibular advancement appliances (MAA), has undoubtedly 
contributed to the increased public awareness of the possibility of controlling 
snoring and sleep apnoea with a dental device. However, in the UK there is no 
agreement as to how the provision of these appliances should be organised or 
funded. Therefore, in order to make progress on these issues it was considered 
that the opinions of hospital doctors and dental practitioners should be sought 
on various questions related to this treatment.  
3.2 Aims 
The primary aim was to identify current practice of dentists in Scotland in the 
management of patients with sleep apnoea or disruptive snoring. The secondary 
aim was to obtain the views of doctors with an interest in sleep medicine on the 
potential involvement of dentists. 
3.3 Materials and Methods 
Draft questionnaires were piloted amongst dentists based in hospital, community 
and general dental practice. These were then amended following feedback. A 
list of dentists in Scotland was obtained from the Dentists Register of the 
General Dental Council and entered into a database. A random number 
generator was then used to select 210 dentists from this database. 
Questionnaires, together with reply-paid envelopes, were sent to these 210 
dentists and a covering letter pledged a donation of £1 to charity for each 
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Seventeen doctors with an interest and expertise in sleep medicine were 
identified. The questionnaire to the doctors simply consisted of 5 questions 
relating to whom they considered should provide an MAA and what screening 
tests should be performed in a primary care setting prior to referral. The 
questionnaire to the dentists consisted of 10 questions to obtain general 
information on the respondents and also their attitude to the provision of MAAs’. 
3.4 Results 
There were 14 replies (82%) from the doctors and 105 (50%) from the dentists. 
There were 12 doctors whose specialty was Respiratory Medicine and 2 from 
other specialities (not specified.) All 14 thought that dentists had a role in 
helping patients with OSAHS or socially disruptive snoring. Twelve doctors (86%) 
felt that dentists could be involved in the screening and referral of patients as 
well as the provision of appliances, with 8 (57%) believing that dentists could 
give lifestyle advice to patients. 
There were 105 replies from the dentists, a response rate of 50%.  The returns 
were relatively evenly split between genders with 53 (50.5%) male and 51 
(48.6%) female, with 1 (1%) not stated.  The average age of respondents was 40 
years (females) and 46 years (males). The questions asked and details of the 
responses are as follows (it should be noted that some respondents did not 
answer every question): 
1. What is your current area of practice? 
The areas of activity of the dentists were Community Dental Service (10), 
Hospital practitioners (9), mixed private and NHS general dental practice (36), 
NHS general dental practice (33), private general dental practice (7), specialist 
practice (3).  
2. How often do you see patients with possible sleep apnoea or chronic snoring? 
There were 101 replies: frequently (1), occasionally (5), infrequently or never 
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3. What do you offer patients with possible sleep apnoea or chronic snoring? 
There were 60 responses (Tables 3.1 and 3.2). 10% did not offer anything, 40% 
would make an appliance, 25% would refer to a sleep clinic and 25% would refer 
to other specialist services.  
4. Would you discuss any side effects of oral appliances with patients? 
There were 58 replies. Yes  -  27 (45%),  No  -  29 (48%).  Details of the side 
effects discussed may be seen in Table 3.3.  
5. Do you currently provide patients with appliances? 
There were 60 replies. 19 (32%) currently provide patients with appliances while 
41 (68%) do not. 
6. What criteria do you use to refer patients to a sleep specialist? 
There were 45 replies. Excessive tiredness was cited by 6 respondents, patient’s 
request by 10 and a high Epworth score by 2. A variety of other factors were 
listed, including severity of symptoms, effect on lifestyle and failure of an 
appliance.  
7. Have you attended any course on the management of sleep apnoea or socially 
disruptive snoring? 
Of the total of 105 returns, 77 (73%) responded “no”, 25 (24%) responded “yes” 
and 3 (3%) did not respond. 
8. With your current level of training, would you be comfortable providing 
patients with oral appliances for sleep apnoea or disruptive snoring? 
From the total of 105 returns, 76 (72.4%) responded that they were not 
comfortable and 25 (23.8%) responded that they were and 4 (3.8%) did not 
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9. Would you be interested in attending a course on the dentists’ role in the 
management of sleep disorders? 
From the 76 respondents to this question, 60 (79%) were interested in attending 
a course and 16 (21%) indicated that they would not be interested in attending.  
From the 25 who responded that they were comfortable providing patients with 
oral appliances, 18 (72%) were interested in attending further training and 7 
(28%) were not.  
10. Do you think that any of your patients would be interested in these 
appliances if you were to offer them? 
82 (78%) thought that they would be, 6 (6%) thought that they might possibly be 
interested, 10 (9%) thought that they would not and 7 (7%) did not respond. 
Finally, dentists were given the opportunity to make any further comments and 
these are listed in Table 3.4. 
 
3.5 Discussion 
As was mentioned already, there have been no previous studies on the current 
practice of dentists in relation to patients with sleep apnoea or disruptive 
snoring, or the views of doctors as to what they believe dentists could offer. 
While this was not a large scale study, the number of responses from both 
doctors and dentists was considered to be sufficient to give an indication of 
current practice in Scotland. Methods have been used to try and increase the 
response rate to questionnaires and it has been suggested that achieving the 
best response rate involves using a monetary incentive, making the 
questionnaire interesting or, as in this study, stating an organisation will benefit 
from their response. (Edwards, Roberts et al. 2002, Edwards, Roberts et al. 
2007) The authors of this study attempted to maximise the response rate by 
promising money to a charity, Oxfam, for all responses received.  Chapter 3      61 
The results of this study indicate that doctors in this field are keen for dentists 
to be involved in the management of these patients however there is no 
consensus who the patient should be referred to. Dentists, on the other hand, 
are not aware of the current patient demand and lack training in this field.   
Most dentists stated patients would be interested in these appliances if offered, 
but only 30% currently provided appliances.  The side effects of mandibular 
advancement appliances have been reported by others, but fewer than 50% of 
dentists in this current survey discussed side effects of the appliances with their 
patients. (Battagel, Kotecha 2005)  
It might be of interest to dentists to note a Position Statement provided by 
Dental Protection Limited in December 2005 on the provision of appliances by 
dentists. In summary, they will assist dentists with any claim provided that: 1) 
the dentist has been trained to provide these appliances, 2) the patient has been 
appropriately assessed for OSA, 3) they have a medical referral if OSA is 
suspected, 4) patients have been warned of possible risks and 5) an appliance is 
part of an integrated treatment plan if OSA is present. 
The role of mandibular advancement appliances was clarified and confirmed by 
the Scottish Intercollegiate Guidelines Network (SIGN) in 2003 and this Guideline 
was endorsed by the British Thoracic Society.
 (Scottish Intercollegiate Guidelines 
Network 2003)Their recommendations are that intra-oral devices are appropriate 
for: 
snorers and patients with mild OSA with normal daytime alertness. 
an alternative therapy for patients who are unable to tolerate CPAP 
(continuous positive airway pressure) 
They also recommend that intra-oral devices should be monitored in order to 
assess the control of OSA and associated symptoms. 
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It will also be of interest to dentists to know that the dental team at 
Practitioner Services, a Division of NHS National Services Scotland (responsible 
for the verification and payment for treatment and services provided by NHS 
primary care dentists in Scotland) have indicated that an NHS fee may be 
available for the provision of an intra-oral appliance for the treatment of OSA if 
full details are provided and prior approval is sought.  
The British Society for Dental Sleep Medicine recently published a draft protocol 
for the management of these patients which has an algorithm that practitioners 
can use which will develop with increased use. There is no evidence the 
algorithm will prove useful or is the most effective method of management and 
is based on expert opinion. (Stradling, Dookun 2009)  
In summary, the current practice of dentists and doctors in relation to dental 
involvement in the management of obstructive sleep apnoea and socially 
disruptive snoring in Scotland is varied. Whilst doctors appear to be happy for 
dentists to be involved, dentists need further training in the provision of these 
appliances, in the use of appropriate screening tests and the possible side 
effects of wearing appliances. Professionals are unclear of the funding available 
under the National Health Service and it is suggested that familiarity with the 
available clinical guidelines on patient management and the involvement of 
dentists could clarify the treatment options for this group of patients. 
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Table 3.1  A list of the services offered by GDPs’ to patients with possible OSA or 
problem snoring.  
Services offered  Number of responses 
No treatment or no data:  7 
Construct appliance:   
      Appliance only  12 
      Appliance and lifestyle advice  5 
      Appliance and referral  4 
      Appliance, advice and referral  4 
Lifestyle advice:   
      Advice only  7 
      Advice and referral  8 
Referral only:  13 
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Table 3.2. Referral patterns of the 29 dentists who included “referral” in their 
management.  
Refer to:  Number 
Sleep clinic  14 
Dental hospital, oral surgery or oral 
medicine 
7 
General medical practitioner  4 
GDP who provides appliances  2 
Orthodontist  1 
ENT surgery  1 
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Table 3.3 Possible issues and side effects of appliances that dentists discussed 
with patients. 
Number  Side effect 
13  Poor compliance 
7  TMJ pain 
5  Oral hygiene 
4  Lack of effectiveness 
2  Hyper-salivation 
2  Caries 
2  Periodontal issues 
1  Appliance hygiene 
1  Social issues 
1  Movement of upper anterior 
teeth  1  Occlusal disruption 
1  Gagging 
1  Dry mouth 
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Table 3.4.  Additional comments made by dentists. 
Generally favourable comments or suggestions 
A list of local sleep clinics for referral would be useful 
Appliances could be offered to a limited number of patients if it is felt that this 
would be of benefit.  
I am happy to make appliances.  
I believe this is more common than is currently acknowledged.  
I do not treat these cases because they do not present at my practice. However, 
I would be interested in learning about them and how to treat.  
I don't think that patients are generally aware that these disorders can be 
treated by dentists. I have never been asked - but I have not offered treatment 
either.  
I've made one appliance which worked very well. Would do it again.  
Not a topic that has come up as yet. However, I would like more information on 
the management of such cases.  
Patients have enquired about 'gum shields'. They were referred to an 
orthodontist who provided an appliance which proved difficult to wear.  
The anti-snoring devices that we have provided have received good feedback. 
Device works well.  
Very interested. This is an under diagnosed and under treated condition.  
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Less favourable or uncertain 
The idea of a tool that could reduce the problem is good, but as I find with bite-
raising appliances for TMJ problems, compliance rate is very low. Patients try it 
for a week then give up.  
Currently working as NHS community dental officer. Are we able to offer this 
service?  
I think most patients would go to their GP first.  
I'd prefer to refer patients to a specialist - hospital or private.  
Difficulty getting onto courses  
Cost aspects 
Appliance provided after sleep clinic consultant. Cost is an issue. Lots would like 
to try it but can't afford it. Good success with careful patient selection.  
Appliances have to be cost effective. Remember it is the partners who are 
disturbed. Sleep apnoea is different.  
Cost could be a problem as NHS do not provide a fee.  
I have offered an appliance to 2 patients but both declined as they considered it 
too expensive.  
Main problem is cost. If this is perceived as a medical problem would the cost be 
borne by NHS?  
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4  Chapter 4 - The Kushida Index as a screening 
tool for Obstructive Sleep Apnoea-Hypopnoea 
Syndrome. 
4.1 Introduction 
The current gold standard for the investigation of OSAHS includes clinical 
examination, assessment of daytime somnolence and an overnight sleep study 
(polysomnography). Many different screening methods have been used to 
attempt to reduce the cost and inconvenience of overnight sleep studies, but 
Pang et al concluded that there needed to be further validation of these 
methods before widespread use could be recommended. (Pang, Terris 2006/0) 
However, one screening method that showed potential, with a sensitivity of 
97.6% and a specificity of 100%, was published by Kushida et al in 1997. 
(Kushida, Efron et al. 1997) The Kushida Index is calculated as previously 
mentioned.  
There have been several recent articles highlighting the possible role of dentists 
in the management of patients with OSAHS. (Lyons, Cameron et al. 2001, 
Jauhar, Lyons et al. 2008a, D. Sword, W. T. N. Lee et al. 2004, Stradling, Dookun 
2009, Lyons 1999, Jauhar, Lyons et al. 2008b) 
The Kushida test appears to be a simple screening test, with good sensitivity and 
specificity, and could be carried out by dentists in general dental practice.  
4.2 Aims 
The aim of this study was to assess the validity and reliability of the Kushida 
Index as a screening tool for OSAHS in a West of Scotland population. A 
secondary aim was to assess whether other factors (Mallampati score, Epworth 
sleepiness score, enlarged tongue, enlarged soft palate, or obstruction due to 
tonsil enlargement) were correlated to the diagnosis of OSAHS.  
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4.3 Materials and Methods 
The Standards for Reporting of Diagnostic Accuracy (STARD) checklist was used 
in this study.(Bossuyt, Reitsma et al. 2003) The study protocol was approved by 
the Glasgow West Local Research Ethics Committee 2. (see Appendix)  A power 
calculation was carried out based on data from Kushida’s study, with the 
assumption of finding 95% sensitivity and 95% specificity, and this indicated that 
a sample size of 73 patients would be appropriate.  85 participants were 
recruited to allow for any drop-outs. A history and clinical examination was 
conducted by a consultant respiratory physician and a specialist registrar. 
Patients were recruited in a consecutive series and informed consent was 
obtained. The inclusion criteria were that subjects should be over 18 years of 
age and who were judged to require a sleep study. Patients were excluded if 
they were involved in other research studies or did not require a sleep study.  
The examiner carrying out the morphological measurements was blinded to the 
clinical history, the provisional diagnosis of the participants and to their sleep 
study results. The following data were obtained:  
1)  Height (m) and weight (kg) to allow calculation of Body Mass Index (BMI) 
2)  Neck circumference at crico-thyroid region in centimetres (cm). 
3)  Palatal height (mm), measured by Jenny Callipers which had the sharp 
points modified. The advantage of these callipers is that there is an adjustable 
screw on one arm so the depth of the palate could be accurately measured 
(Figure 4.1).  The callipers were sterilized before use and disposable plastic 
coverings were used for each patient. The measurement was taken from the 
midline of the dorsal surface of the tongue at the median lingual sulcus to the 
highest point in the palate, measured with the tongue in a relaxed position. The 
measurement was taken at 20 degrees of mouth opening which was established 
by a plastic goniometer. (Figure 4.2) 
4)  Maxillary and mandibular inter-molar distance (mm), measured from the 
mesial surface of the second molars with jenny callipers. If these teeth were 
missing, an estimate was made of the position of the mesial surface of second 
molars using associated anatomy and teeth present. If patients wore dentures at 
night, measurements were taken of the denture teeth. (Figure 4.3) 
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These measurements were then used in the Kushida formula to calculate the 
Kushida Index.  
 
Additional non-interventional measurements collected were: 
1)  Unit number 
2)  Sex 
3)  Age 
4)  Date of examination 
5)  Epworth score (at a later date from patient’s notes) 
6)  Teeth present 
7)  Incisal relationship 
8)  Visual inspection of the tongue. 
9)  Visual airway evaluation and assignment of Mallampati score (see below) 
10)  Visual inspection of nasal passage to assess patency. 
 
The Mallampati score is a scoring method to assess the ease of intubation of a 
patient, graded on a scale of 1-4. (Figure 4.5) The use of the Mallampati score 
was based on studies of the use of this score as a clinical predictor for 
OSAHS.(Friedman, Tanyeri et al. 1999, Liistro, Rombaux et al. 2003, Nuckton, 
Glidden et al. 2006) This scoring method is used in anaesthetics to assess the 
ease with which the upper airway may be visualised during tracheal 
intubation.(Mallampati, Gatt et al. 1985b, Samsoon, Young 1987)  
 
Participants all had limited sleep studies (respiratory polysomnography) carried 
out using the Somnoscreen system (S-Med, UK) and manually analysed by a sleep 
technician (DM). The diagnosis of OSAHS was based on the daytime somnolence 
(an Epworth Sleepiness score ≥10) and an Oxygen De-saturation Index (ODI) 
≥10/hr. The criteria for the diagnosis of OSAHS were based on the 
recommendations in SIGN Guideline Number 73 and on local protocols and were 
as follows:  ODI less than 10 was considered normal, 11-15 
inconclusive/borderline, 16-20 mild, 21-30 moderate, and 31 or greater was 
considered severe.  (Scottish Intercollegiate Guidelines Network 2003) 
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4.3.1 Statistical Methods 
 
Statistical calculations were carried out using Minitab and SPSS.  Differences 
between means and 95% confidence intervals for each variable in OSAHS and 
normal patients, were calculated. P-values were calculated using an 
Independent T Test if the data were normally distributed. Where data were not 
normally distributed, Mann Whitney tests were used as the sample size was not 
sufficiently large for large sample assumptions of normality.  Correlations were 
calculated using a Pearsons Correlation Coefficient for normally distributed data 
and a Spearmans Rank Correlation Coefficient for non-parametric data.  When 
comparing categorical data, a Chi Square test was used. If the expected count 
was less than 5, a Fishers exact test was used. 
 
Sensitivity is the proportion of true positives (respiratory PSG confirmed OSAHS) 
that are correctly identified by the screening test (Kushida). Specificity is the 
proportion of true negatives (respiratory PSG confirmed not OSHAS) that are 
correctly identified by the screening test (Kushida).(Altman, Bland 1994b) 
 
Positive predictive value is the proportion of patients with positive test results 
(Kushida positive) who are correctly diagnosed. Negative predictive value is the 
proportion of patients with negative test results (Kushida negative) who are 
correctly diagnosed.(Altman, Bland 1994a) 
 
4.4 Results 
 
85 participants were recruited from Gartnavel General Hospital Sleep Clinic, in 
Glasgow, Scotland, between May and November 2007. However, of these 10 
failed to attend for the sleep study and 4 were edentulous and did not wear 
their dentures at night.  
Of the 71 patients subsequently included in the study, 49 (69%) were fully 
dentate, 8 (11%) were partially dentate with enough teeth to estimate the intra-
oral distances but missing one or more second molar teeth, 10 (14%) were 
partially dentate but had all the teeth required for calculation of the Kushida 
index present, and 4 (6%) were edentulous but slept with their dentures in at 
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The demographics of the patients initially recruited and those finally included in 
the study are summarised in Table 4.1. There were no statistically significant 
differences between these two groups in the variables listed in Table 4.1.  
The occlusal pattern and morphological measurements of the subjects are 
summarised in Tables 4.2 and 4.3.  
In some patients when the AHI was not available, the ODI was used, as is often 
done in clinical practice.   There was a highly significant correlation between 
the ODI and AHI (r = 0.77; p<0.001, n= 52). Compared to patients without OSAHS, 
patients with OSAHS were older (50 ± 10.2 years vs 42.85 ± 11.1, p = 0.006), had 
a higher BMI (35.8 ± 9.4 vs 28.9 ± 6.1, p < 0.001) and a larger collar size (43.2 ± 
4.1 vs 39.2 ± 2.9, p < 0.001)  (Table 4.4).  
The cut-off used for a positive Kushida Index was 70, based on previously 
published data. (Kushida, Efron et al. 1997) The sensitivity of the Kushida Index 
in this present study was 68%. (95% CI 50 - 81) and the specificity was 71% (95% 
CI 52 - 84).  The positive predictive value was 71%; the negative predictive value 
was 67%. (Table 4.5) 
 
The receiver operator curve (ROC) for the Kushida Index and a diagnosis of 
OSAHS is presented in Figure 4.3 and consists of a plot of the true positive rate 
(sensitivity) against the false positive rate (specificity) for different subjects. A 
test with perfect discrimination (no overlap in the two distributions) has a ROC 
plot that passes through the upper left corner (100% sensitivity, 100% 
specificity). Therefore the closer the ROC plot is to the upper left corner, the 
higher the overall accuracy of the test.(Zweig, Campbell 1993) 
The diagnostic category of the patients achieved by using our criteria may be 
seen in Table 4.6. The Mallampati score, Epworth sleepiness score and 
enlargement of the tongue, soft palate or tonsils were not significantly related 
to a diagnosis of sleep apnoea (p > 0.05).  
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4.5 Discussion 
 
The sensitivity and specificity of the Kushida Index for the prediction of OSAHS 
were found to be rather lower in this present study compared to Kushida’s 
original results. Kushida’s formula was originally based on data from 30 subjects 
and then prospectively tested on a further 300 subjects. (Kushida, Efron et al. 
1997) This formula has been further tested in Brazil by Soares et al on 80 
subjects and in Korea by Jung et al on 54 subjects. (Soares, de Azeredo 
Bittencourt et al. 2006, Jung, Cho et al. 2004) The inclusion of 71 subjects in 
this present study has been calculated to give 80-90% adequate power at the 5% 
significance level. In Kushida’s study, the sensitivity of the index was found to 
be 97.6% and the specificity was 100%, rather higher than the 68% and 71% of 
this present study. Jung (2004) also reported higher figures, with sensitivity of 
89% and a specificity of 94%. All of these figures are based on a cut-off value of 
70 in the Kushida Index.  
 
One possible reason for the difference in the sensitivity and specificity in our 
study was that we used a higher threshold level for sleep apnoea (>11) than the 
original study by Kushida (>5).  The reason for using a higher level was that an 
AHI of >5 is no longer considered to represent clinically significant sleep apnoea, 
which was not the case when Kushida published his data in 1997. (Scottish 
Intercollegiate Guidelines Network 2003) However, when we calculated the 
results using Kushida’s definition of OSAHS, we obtained a sensitivity of 60% and 
a specificity of 76%. These values are too low to validate the Kushida Index in 
our population.  
  
The gender and age distributions are similar in previous studies to this present 
study. (Kushida, Efron et al. 1997, Soares, de Azeredo Bittencourt et al. 2006, 
Jung, Cho et al. 2004) However, Kushida et al was the only other group to 
publish the Epworth score; they found a larger difference (mean difference 4) 
between those with OSAHS and those without compared to the findings of this 
present study (mean difference 0.1). However, the range of Epworth scores in 
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unlikely that this is the reason for the difference in the sensitivity or specificity 
between this present study and Kushida’s study. 
 
There were similar neck circumferences found in all studies cited, but perhaps 
the largest difference between these studies was in the intra-oral 
measurements. In comparison to Kushida, Jung and our own results, Soares et al 
found smaller maxillary and mandibular intermolar distances and lower palatal 
heights. This may be due to differences in craniofacial characteristics in that 
demographic area. 
 
This present study was prospective in design, with sufficient participants to 
achieve a power of 80%. Although the sensitivity and specificity are considerably 
lower than those found by others, we are confident that these results are valid 
for the population studied. All patients were recruited in a consecutive order 
and the number of those diagnosed with OSAHS was similar to the number of 
healthy controls. The intra-oral measurements were carried out by one 
calibrated operator (SJ) who was also blinded to the history and presenting 
complaint of the patients.  A test of the reproducibility of the measurements 
was carried out on volunteers prior to the study. The sleep technician (DM) is 
employed in a large sleep department and has been trained to ARTP (Association 
of Respiratory Technology and Physiology) standards and complies with ARTP 
Standards of Care for Sleep Apnoea Services. 
It could be argued that all subjects without second molar teeth and anterior 
maxillary and mandibular incisor teeth perhaps should have been excluded from 
the study as it was not possible to make the intra-oral measurement in the way 
that Kushida intended. However, this would have distorted the applicability of 
the test in the West of Scotland area where a significant proportion of patients 
are partially dentate or edentulous. Therefore these patients were included if 
there was sufficient detail to reliably estimate the required intra-oral 
measurements. 
In previous studies, if a subject had a nasal obstruction and a high Mallampati 
score this was correlated to a diagnosis of OSAHS.(Liistro, Rombaux et al. 2003) 
However, even without nasal obstruction, those with a Mallampati score of 3 or 
4 have been reported to have a 1.95 relative risk of having OSAHS.(Nuckton, 
Glidden et al. 2006) The Mallampati score could be easily carried out by dentists Chapter 4      75 
as part of a screening procedure, but in our study a high Mallampati score was 
not correlated to a diagnosis of OSAHS. 
 
4.6 Conclusions 
 
The Kushida test is quick, simple and non-invasive to perform and could easily be 
applied in the dental surgery. However, with the limited sensitivity and 
specificity demonstrated in this study, it cannot be recommended as a screening 
test. A primary care based large scale study would be required before it could be 
recommended as a routine screening test for those with a high suspicion of 
OSAHS prior to referral to a sleep clinic. 
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 Figure 4.1 Jenny Callipers 
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Figure 4.2 Goniometer 
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Figure 4.3 Measurement of mandibular intermolar distance  
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Figure 4.4. Modified Mallampati Score (Samsoon GL, Young JR. 1987) 
Class 1: Full visibility of tonsils, uvula and soft palate 
Class 2: Visibility of hard and soft palate, upper portion of tonsils and uvula 
Class 3: Soft and hard palate and base of the uvula are visible 
Class 4: Only Hard Palate visible Chapter 4      80 
 
 
 
 
Variable  Number 
Recruited 
Mean (SD) 
values for 
those 
recruited 
Range of 
values for 
those 
recruited 
Number of 
patients 
included in 
study 
Mean (SD) 
values for 
those 
included 
Range of 
values for 
those 
included 
Age  85  47.6 (11.2)  21-78  71  46.6 (11.2)  21-78 
Gender  85  63 Males    71  53 males   
Neck 
circumference 
(cm) 
84  42 (4.8)  33-58.4  71  41.3 (4.1)  33-57.15 
BMI  85  33.7 (8.8)  19.4-64.3  71  32.5 (8.7)  19.4-64.3 
Kushida Index  84  74.2 (21.9)  31-142.6  71  71.3 (21.3)  31-142.6 
Modified 
Mallampati 
Score 
85  3.3 (0.96)  1-4  71  3.2 (0.99)  1-4 
Epworth 
Sleepiness 
Score 
85  11.8 (5.5)  0-24  71  11.1 (5.4)  0-21 
 
Table 4.1 Comparison of demographics of patients included and excluded from 
the analysis. 
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 Incisal relationship  Frequency (%) 
Class  I  39 (55) 
 Class  II div I  14 (20) 
 Class  II div II  7 (10) 
 Class  III  11 (15) 
 Total    71 (100) 
 
Table 4.2 Incisal relationship of patients 
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Overbite 
(mm) 
Overjet 
(mm) 
Palatal 
height (mm) 
Maxillary 
inter-molar 
distance (mm) 
Mandibular 
inter-molar 
distance (mm) 
N    71  71  71  71  71 
Mean  1.9  2.2  40.1  40  41.5 
SD  1.6  2  7  3.7  4.6 
Minimum  0  -1  26  34  31 
Maximum  6  11  55  50  52 
 
Table 4.3 Pooled intra-oral measurements of all patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients with 
OSAHS (n=37) 
Patients without 
OSAHS (n=34) 
Mean Difference 
(95%CI)  
P Value 
* Chapter 4      83 
Table 4.4 Results for the 71 patients included in the study 
* P values are from Independent t-tests or Mann Whitney tests 
Sex M:F  30:7  23:11     
Age (years), mean 
(SD)  50 (10.2)  42.85 (11.1)  -7.1 (-12.2, -2)  0.006 
BMI, kg/m
2 ) mean 
(SD)  35.8 (9.4)  28.9 (6.1)  -6.8 (-10.6, -3.1)  <0.001 
Neck 
circumference 
(cm)  
mean (SD)  43.2 (4.1)  39.2 (2.9)  -4 (-5.7, -2.3)  <0.001 
Maxillary inter-
molar distance 
(mm) mean (SD)  40.8 (3.7)  39.1 (3.5)  -1.7 (-3.4, 0.3)  0.54 
Mandibular inter-
molar distance 
(mm) mean (SD)  42.5 (4)  40.4 (4.8)  -2.1 (-4.2, -0.2)  0.048 
Palatal height 
(cm) mean (SD)  39.2 (7.3)  41 (6.5)  1.86 (-1.4, 5.1)  0.264 
Overjet Median 
(Range) {IQR}   2 (-1,8) {.5,3}  2 (0,11) {1.38,3}    0.467 
 
ODI Median 
(Range) {IQR} 
24 (11,68) 
{16.3,38}  3 (0,9) {1,6}    <.001 
 
Kushida Index 
mean (SD)  79.2 (21.7)  62.8 (17.5) 
-16.5 (-25.9, -
7.1)  <0.001 
 
Epworth 
Sleepiness Score 
mean (SD)  10.4 (5.5)  10.3 (5.6)  -1.4 (-3.96, 1.15)  0.27 Chapter 4      84 
 
  OSAHS Present  OSAHS Absent  Total 
Kushida Positive  25  10  35 
Kushida Negative  12  24  36 
Total  37  34  71 
 
Table 4.5 Relationship between the diagnosis obtained from respiratory 
polysomnography and the results of the Kushida Screening test. 
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Diagnosis from Sleep Study 
Number 
of patients 
Normal  34 
Inconclusive/borderline OSAHS  8 
Mild OSAHS  9 
Moderate OSAHS    7 
Severe OSAHS  13 
 
Table 4.6 The diagnostic category of the 71 patients included in the study. Chapter 4      86 
 
 
 
Figure 4.5 The Receiver Operator curve for the Kushida Index in the diagnosis of 
OSAHS.  
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5  Chapter 5 - Summary and recommendations for 
future research. 
 
From the studies presented in this thesis, it is clear that doctors involved in 
sleep medicine see a role for dentists in treating patients with chronic snoring 
and mild OSAHS, the oral appliances made can work well for patients over a long 
period of time, but the methods dentists should use to screen for sleep apnoea 
before construction of an appliance and the clear need for training in this field is 
still to be addressed. 
I suggest that the profile of sleep medicine and its relationship to dentistry 
needs to be raised. It would be beneficial to conduct a primary care based study 
that could analyse if screening tests such as the Kushida Index and Epworth 
Sleepiness Score are appropriate screening tools to rule out sleep apnoea so 
dentists could construct an appliance for patients with snoring alone without 
being concerned that the patient has underlying OSAHS with subsequent medical 
complications. 
One very interesting future study would be to investigate the effect of denture 
wearing at night on OSAHS in edentulous patients as previous reports highlight 
this may help, however these studies are underpowered and have not been 
validated.88 
Appendices 
EPWORTH SLEEPINESS SCALE 
How likely are you to doze off in the following 
situations (in contrast to just feeling tired)?  Even if 
you have not done some of these things, try to work 
out how these situations would affect you.  Use the 
following scale: 
0  =  would never doze 
1  =  slight chance of dozing 
2  =  moderate chance of dozing 
3  =  high chance of dozing 
  Situation        Chance of dozing   
1.  Sitting and reading    ________ 
2.  Watching TV      ________ 
3.  Sitting, inactive in a public place (e.g., a theatre 
or a meeting)        ________ 
4.  As a passenger in a car for an hour without a break
            ________ 
5.  Lying down to rest in the afternoon when 
circumstances permit    ________ 
6.  Sitting and talking to someone________ 
7.  Sitting quietly after a lunch without alcohol 
            ________ 
8.  In a car, while stopped for a few minutes in traffic
            ________ 
  Total          ________ 
Epworth sleepiness Scale. Johns MW (1991). "A new method for measuring 
daytime sleepiness: the Epworth sleepiness scale". Sleep 14 (6): 540–5. Scores 
greater than 10 merit referral to a sleep physician. 89 
Stanford Sleepiness Scale (SSS) 
 
Degree of Sleepiness Scale               Rating  
 
Feeling active, vital, alert, or wide awake           1  
 
Functioning at high levels, but not at peak; able to concentrate     2  
 
Awake, but relaxed; responsive but not fully alert         3  
 
Somewhat foggy, let down               4  
 
Foggy; losing interest in remaining awake; slowed down       5  
 
Sleepy, woozy, fighting sleep; prefer to lie down         6  
 
No longer fighting sleep, sleep onset soon; having dream-like thoughts   7  
 
Asleep                     X  
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Patient questionnaire 
Name__________________________  Date:______________  (ref  no:  office u s e ) -
___ 
Please tick a box, where appropriate. Please ask your partner if appropriate to 
help fill in some areas. 
A.  How many days of the week do you wear the appliance? 
1  □  2   □  3  □  4   □  5   □  6   □ 7  □ 
B.  How comfortable is the appliance to wear?  
Very uncomfortable  □  Slightly uncomfortable  □  Comfortable  □ 
C.  Did the appliance make a difference to your snoring? 
No □  Slightly better  □  Much better □ 
D.  How satisfied are you with the appliance? 
Not satisfied  □ Satisfied  □ Very satisfied  □ 
E.  Were there any side effects from wearing the appliance: 
____________________________________________________ 
____________________________________________________ 
1.  How many hours of sleep a night do you get? 
1-3 □  4-6 □   7-9 □ >9  □ 
2.  Do you wake up feeling refreshed? 
No □  Sometimes  □    Yes  □ 
3.  Do you feel sleepy during the day? 
No □  Sometimes  □    Yes  □ 
 
4.  What position do you sleep in when you snore? (can tick more than one if 
applicable) 
On back ￿    On front ￿  On side ￿  Don’t know ￿ 
5.  Present body weight_____st_____lbs 91 
Height______ft______inches 
(Office use) BMI _____________ 
 
6. Do you smoke?  Yes   □  No  □ 
Cigarettes  □   Cigar  □  Pipe  □ 
1-4 per day □  6-15 per day □  >15 per day □ 
7. Do you drink alcohol: Yes   □    No  □ 
Alcohol consumption: In units (1 unit is a glass of wine or a spirit, a pint of 
beer is 2 units)   0 □  5-10 □  10-20 □  20-30 □  30-40 □  >40 □ 
8.  How would you rate the quality of your sleep? 
Poor  □    Average  □    Good  □   
9.  Do you know if you suffer from sleep apnoea, if so what category are you 
in? 
Don’t know  □  Mild □  Moderate □ Severe □ 
10. How motivated are you to stop or reduce your snoring? 
Not really □  Partner more than me  □    Very motivated  □   
11. In summary please rate the overall success of the appliance 
Poor  □  OK  □     Good  □   
COMMENTS 
___________________________________________________________ 
___________________________________________________________ 
___________________________________________________________ 
 
Thank you for taking the time to fill out this questionnaire. 92 
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